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ABSTRACT OF THE DISSERTATION
Molecular Mechanisms of Programmed Necrotic Death Initiated by Intrinsic Death Signals
by
Gary Xiaoshi Wang
Doctor of Philosophy in Biology & Biomedical Sciences
Molecular Cell Biology
Washington University in St. Louis, 2014
Professors Emily H.-Y. Cheng, Chair, and Kendall J. Blumer, Co-Chair

Proper regulation of cell death is critical for tissue development and homeostasis, with
deregulation implicated in many illnesses. Cell death is morphologically categorised as apoptosis,
autophagy, and necrosis, with apoptosis being the best studied. BCL-2 family members are
critical apoptosis regulators. Death signals induce upstream “activator” BH3-only molecules to
activate the essential mitochondrion apoptosis effectors BAX and BAK to execute death. Yet,
combined loss of Bax and Bak causes developmental and homeostatic defects in restricted
-/-

tissues, indicating the existence of additional death program(s). By using Bax Bak

-/-

double-

knockout (DKO) mouse embryonic fibroblasts (MEFs) to study non-apoptotic death, we
discovered DNA double strand breaks (DSBs) activate a genetic program that upregulates
reactive oxygen species (ROS) and the lysosomal protease cathepsin to execute a form of
“programmed necrotic death” (PND). This refutes the long-held view that necrosis is a passive
reponse to unmanageable physico-chemical stress. However, the PND execution pathways
triggered by death signals and the determinants of death versus long-term survival are unclear.
Here, I demonstrated a critical role for the transcription factor ΔNp63α in determining
long-term survival in the face of oxidative stress, a central necrotic mediator. ΔNp63α protected
DKO MEFs against PND and enhanced long-term survival via a novel ability to control
intracellular redox homeostasis by regulating glutathione metabolism. ΔNp63α overexpression
protected from oxidative stress induced by oxidants, DNA damage, and anoikis, while deficiency
of ΔNp63α increased oxidative stress and sensitized to oxidant-induced death. I further found that

	
  

ix

long-term survival of anchorage-dependent cells following loss of matrix attachment was
enhanced by combined inhibition of apoptosis and oxidative stress by BCL-2 and ΔNp63α,
respectively. Furthermore, I showed that in DKO MEFs, DSBs triggered an ATM-mediated DNA
damage response that increased ROS production by upregulating the activity of complex III of the
electron transport chain. My work concluded a key role for oxidative stress in the loss of long-term
survival triggered by intrinsic death signals and revealed an important role for ΔNp63α in
regulating redox homeostasis. These findings laid the groundwork for future studies on
programmed necrotic death initiated by intrinsic death signals.
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-CHAPTER ONE-

Introduction
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1.1 Introduction
For metazoans, the ability of individual cells to respond correctly to pro-survival and pro1

death signals is central to embryonic development and tissue homeostasis . Accordingly,
2

dysregulated cell death contributes to the pathogenesis of many human diseases . Insufficient
cell death can lead to cancer and autoimmunity while execessive cell death is implicated in
2

neurodegeneration and ischemic injury . Although cell death has been recognized since the
th

1800s to be a normal part of embryonic development, it was not until the latter half of the 20
3

century that fundamental insights on the regulation of cell death began to emerge . Not
surprisingly, these insights have opened many avenues for therapeutic intervention in a broad
4

range of pathological settings .
Cell death is categorized into three forms based on morphological features (Fig. 1.1). The
first form, apoptosis, has been the most extensively studied and is characterized by prominent
nuclear condensation and fragmentation, preservation of plasma and organelle membrane
5

integrity, and formation of apoptotic bodies . It is an evolutionarily conserved, highly regulated,
5

genetically encoded process that has long been synonymous with “programmed cell death” . The
second form is autophagic cell death, characterized by the formation of double membrane
vesicles, i.e. autophagosomes. Autophagy is mainly a prosurvival mechanism to help cells during
nutrient deprivation, yet exessive autophagy certainly compromises the survival of cells and leads
5

to cellular demise . The third form is necrosis, which features cytoplasmic translucency, irregular
chromatin condensation, organellar and cellular swelling, loss of plasma and organelle membrane
integrity, and spillage of intracellular contents into the extracellular space

5, 6

.

Necrosis was traditionally thought to be an unregulated, accidental outcome of exposure
7

to unmanageable physico-chemical stress . The first clue to indicate otherwise came in 1988
when it was reported that tumor necrosis factor (TNF) can induce either apoptosis of necrosis,
8

depending on the cell type . Accumulating evidence since then, both from our lab and many
others, have established the existence of molecular mechanisms that control necrotic death

9, 10

.

This recent emergence of “programmed necrotic death” represents a true paradigm shift in a field
that has long equated “programmed cell death” with “apoptosis”. It is important to note that, in the
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absence of phagocytic clearance, the morphological endpoint of all types of cell death will
6

resemble necrosis due to the eventual loss of plasma membrane integrity . This consequence of
the gradual degradation of biological materials over time is referred to as secondary necrosis and
6

is distinct from primary necrosis, which describes a cell death mechanism .
In both apoptosis and programmed necrosis, diverse signals ultimately converge on the
molecular mechanisms that integrate and interpret these cues to make critical life or death
decisions for the cell

1, 10

. In the case of apoptosis, execution of cell death is mediated by
1

caspases, a family of cysteine proteases activated by extrinsic or intrinsic death signals .
Caspase activation results in the stereotypical biochemical and morphological hallmarks of
5

apoptosis; therefore, caspase-dependent cell death is synonymous to apoptosis . Although the
pathways that initiate and execute programmed necrosis have not been as extensively elucidated
as the ones that control apoptosis, clear themes have emerged. Similar to apoptosis, both death
10

receptor ligation and intrinsic death signals can trigger programmed necrosis . However, unlike
10

apoptosis, the execution of programmed necrosis does not rely on caspases . Rather, evidence
suggest it involves a complex interplay of reactive oxygen species (ROS), organelle dysfunction,
10

and dysregulated intracellular calcium homeostasis . The mitochondria and lysosomes have
7

emerged as the target organelles within this network of effectors . The aim of this thesis is to
further our understanding of the molecular mechanisms that govern programmed necrotic death
in response to intrinsic death signals.

1.2 Apoptosis
Introduction
Though there are reports going as far back as the 1800s describing cells that appeared
to die as a normal part of development, cell death was not established to be a normal biological
3

process until Alfred Glucksmann’s comprehensive 1951 review . In that article, he summarized
and categorized instances of cell death observed during vertebrate development and stated that
3

these cells shared a set of morphological characteristics that we now recognize as apoptotic .
Then in 1965, Richard Lockshin and Carroll Williams, in a report on the death of larval muscles of
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metamorphosing insects, introduced the term “programmed cell death” to describe this form of
death that appeared to be triggered in otherwise healthy cells by a specific series of physiological
11

events versus death elicited by toxic or inhospital environments . In that same year, the
pathologist John Kerr proposed the term “shrinkage necrosis” to describe the process that
resulted in the appearance of small, condensed, acidophilic, enucleated cytoplasm in the liver
12

under pathological conditions . Then, in a landmark 1972 study, Kerr and colleagues changed
that term to “apoptosis” to clearly distinguish it from necrosis and to highlight its presumed
importance in the regulation of tissue cell number under both physiological and pathological
13

conditions . In that study, apoptosis was described to occur in two discrete, sequential stages.
The first stage is marked by condensation of the nucleus and cytoplasm, nuclear fragmentation,
and breaking up of the cell into numerous membrane-bound, well-preserved cell remnants i.e.
apoptotic bodies. In the second stage, apoptotic cells are ingested by neighboring cells and
degraded within phagosomes. Histologically, apoptosis was observed to result in minimal tissue
disruption with no evidence of inflammation. Based on previous findings in developmental biology
and the histological and ultrastructural features of apoptosis, the authors believed apoptosis to be
the regulated process responsible for counterbalancing cell proliferation to ensure normal
development and tissue homeostasis.

Genetic control of programmed cell death in Caenorhabditis elegans
Based on the observation that a wide variety of simuli were able to initiate the
stereotyped events of apoptosis, Kerr and colleagues suggested that “apoptosis [may depend] on
13

the expression of part of the genome, which is normally repressed in viable cells” . A series of
studies performed using the nematode Caenorhabditis elegans by Sydney Brenner, John
Sulston, and H. Robert Horvitz established that programmed cell death in the worm is indeed a
14

genetically regulated process . Cell lineage tracings performed by Brenner and Sulston using the
C. elegans hermaphrodite demonstrated that over the course its development, the same 131 cells
out of the initial 1090 always died. Subsequent mutagenesis studies carried out by Horvitz and
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colleagues identified the genes that constitute the core pathway governing programmed cell
death in C. elegans.
The first three cell death genes identified in C. elegans were nuc-1, ced-1, and ced-2.
Nuc-1 was discovered by Sulston when he observed that in one particular mutant, denselystaining masses of DNA were found at the locations of cells that normally undergo programmed
14

cell death . He discovered that the gene defined by this mutant encoded a DNA endonuclease
responsible for DNA degradation during cell death. Ced-1 and ced-2 were then identified as two
15

genes responsible for the phagocytosis of dead cells . In these mutants, the death process is
initiated but the cell remants persist due to defective clearance from the surrounding tissue,
15

allowing the cell corpses to be readily visualized in living animals . Horvitz and colleagues
carried out subsequent mutagenesis screens of programmed cell death regulators on a ced-1
mutant background to exploit the persistence of dead cells in this mutant and identified a mutant
in which no cell corpses could be found

16

16

. The gene defined by this mutation is ced-3 , later

cloned and found to be a cysteine protease homologous to a mammalian protease, the
17

interleukin-1β converting enzyme (ICE) or caspase-1 . Subsequent screens uncovered the rest
of the core C. elegans cell death regulatory pathways: the pro-death genes egl-1

18

16

and ced-4 ,

19

and the anti-death gene ced-9 . In response to death signals, Egl-1 is transcriptionally
upregulated and undergoes mitochondrial translocation, where it displaces CED-4 from its
20

inhibitor CED-9 . Once released from CED-9, CED-4 translocates to the perinuclear region,
oligomerizes, and interacts with CED-3 to promote its autocatalytic activation

1, 21

. For their work,

Brenner, Sulston, and Horvitz were honored with the 2002 Nobel Prize in Physiology or Medicine.

Mammalian apoptosis: caspases
As in C. elegans, the execution of apoptosis in mammalian cells likewise depends on the
activity of a family of proteases. The mammalian CED-3 homologue ICE, or caspase-1, is the
founding member of this family of proteases that use a cysteine nucleophile to catalyze peptide
22

bond hydrolysis in motifs bearing aspartic acid . Thus they are named caspases, a contraction of
cysteine-dependent aspartate-specific protease. Synthesized as catalytically inactive zymogens,
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22

caspases possess an N-terminal prodomain followed by a large and small subunit . The human
genome encodes 11 caspases, traditionally split into two major subgroups based sequence
23

homology and function . The first group are “inflammatory” caspases, which are primarily
activated in cells of the innate immune system to regulate inflammation through the processing of
cytokines

23

. The second group consist of “apoptotic” caspases, activated during apoptosis and
23

responsible for the execution of the death program . The apoptotic caspases are further
subdivided into upstream initiator caspases that are activated by adaptor-induced proximity and
24

downstream effector caspases that are cleaved and activated by initiator caspases . Initiator
caspases possess a long prodomain that mediates interactions with their adaptor proteins while
24

effector caspases possess a short prodomain . There are two varieties of initiator caspase
24

prodomains: the caspase-recruitment domain (CARD) and the death-effector domain (DED) .
Activation of inactive monomeric initiator caspases requires homodimerization mediated
25

by their recruitment to activation complexes formed following an apoptotic signal . According to
the induced proximity model, homotypic interactions between the caspase prodomain and
adaptor proteins in these complexes activate caspases via an enforced increase in local caspase
25

concentration . Three mammalian apoptotic initiator caspase activation complexes have been
26

identified: the apoptosome, the death-inducing signalling complex (DISC), and the PIDDosome .
The apoptosome describes a complex of cytochrome c, APAF-1 (apoptotic protease activating
27

factor-1), and caspase-9 . The APAF-1 CARD domain, which mediates interaction with caspase9, is normally bound by two C-terminal WD40 domains and thus unable to bind with the
28

caspase . Upstream death signals that culminate in the permeabilization of the mitochondrial
outer membrane (MOM) release cytochrome c, which binds to APAF-1 through its WD40
28

domains, making its CARD domain available to recruit caspase-9 . Inactive APAF-1 also binds
28

one molecule of ADP/dADP via its nucleotide binding domain . Conformational changes in
APAF-1 due to interaction with cytochrome c allows ADP/dADP to be exchanged for ATP/dATP,
the hydrolysis of which induces a conformational change that permits its oligomerization into the
heptameric apoptosome

29, 30

. The prototypical DISC is formed following ligation of the Fas death

31

32

receptor . Fas, which is preassembled in the plasma membrane as a trimer , undergoes a
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conformational change mediated by weak protein-protein interactions resulting from ligandinduced receptor clustering, leading to the assembly of the adaptor protein FADD to its
33

cytoplasmic tail, which in turn recruits caspase-8 via the DED . This results in high local
25

concentrations of caspase-8, leading to its proximity-induced activation . Finally, the PIDDosome
is the caspase-2 activating complex composed of caspase-2, the adaptor protein RAIDD, and
PIDD, in which proteolytically activated PIDD recruits RAIDD and caspase-2 leading to its
34

activation .
Effector caspases exist as inactive dimers that are activated following proteolytic
cleavage between their large and small subunits by initiator caspases and by the lymphocyte22

specific serine protease granzyme B . Structural studies on caspase-7, a representative effector
caspase, demonstrates the mechanistic basis for proteolytic activation

35, 36

. Following cleavage,

the core structural elements of caspase-7 remain unchanged and the protease remains as a
homodimer. However, drastic conformational changes of active site loops shift the active site from
a closed state to an open one capable of binding substrate. Once active, effector caspases go on
to cleave their intracellular targets to execute apoptosis. A large number of proteins have been
reported to be in vivo caspase substrates, with targeted proteomics approaches revealing that
over 200-300 cellular proteins are cleaved in a caspase-dependent manner following induction of
apoptosis

37, 38

. Of note, the organized degradation of nuclear DNA into 180 bp internucleosomal
39

fragments, one of the key hallmarks of apoptosis, is mediated by the DNase CAD . In the
39

absence of apoptotic signals, CAD is sequestered in the cytoplasm by its inhibitor ICAD . Once
activated either via the DISC or the apoptosome, effector caspase-3 cleaves ICAD, releasing
40

CAD to translocate into the nucleus to degrade chromosomal DNA .
Besides regulating its activation, cells also possess additional regulatory mechanisms to
25

prevent unwanted, potentially lethal caspase activity . First, caspase inhibition is exemplified by
the human caspase inhibitor XIAP, the most extensively studied member of the inhibitor of
41

apoptosis (IAP) protein family . This multidomain protein achieves selective tight inhibition of
both initiator (caspase-9) and effector (caspase-3 and -7) caspases via utilizing a two-site
41

mechanism . Caspase inhibition is also mediated by decoy proteins that structurally mimic
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caspase prodomains to compete for the same adaptors in activation platforms. For example,
FLIP, a caspase-8 mimic with a nonfunctional catalytic domain, prevents caspase-8 recruitment
to the DISC

42, 43

. Finally, inhibition of caspase activity can be achieved via proteosomal

degradation, with cellular IAPs, which contain domains involved in ubiquitin ligation, proposed to
mediate proteosomal removal of caspases

25, 44, 45

.

Intrinsic and extrinsic mammalian apoptosis pathways
1

In mammals, apoptosis can be initiated via either the intrinsic or the extrinsic pathway .
The intrinsic pathway is activated by a wide range of stimuli including DNA damage, ER stress,
1

and cytokine/growth factor depletion . Upstream pro-survival and pro-death signals are
transduced and integrated by the BCL-2 family of proteins, which controls apoptosis by regulating
1

mitochondrial outer membrane (MOM) integrity . MOM permeabilization, generally considered to
irreversibly commit the cell to death following intrinsic death stimuli, leads to the release of
cytochrome c

46

47

as well as other apoptogenic molecules such as Endo G , Smac/DIABLO

48, 49

,

50

and HtrA2/OMI , and from the intermembrane space (IMS).
The extrinsic pathway is triggered by the ligation of cell surface death domain-containing
1

receptors such as Fas, TNFR1, and DR4/5 . Receptor ligation leads to the formation of the DISC
and caspase activation, as described in the previous section. Depending on whether or not MOM
permeabilization is required for the DISC to induce effector caspase activation and cell death,
51

cells can be divided into two types . Type I cells, typified by T lymphocytes, do not require MOM
permeabilization and cytochrome c release for effector caspase activation, and therefore are not
protected by inhibition of MOM permeabilization by overexpression of anti-apoptotic BCL-2 family
51

members BCL-2 or BCL-XL . In those cells, a large amount of caspase-8 is recruited to and
activated at the DISC, leading to effector caspase activation. In contrast, Type II cells, typified by
hepatocytes, have lower levels of caspase-8 and higher levels of XIAP compared to Type I cells,
thus abrogating the ability of caspase-8 to directly activate effector caspases

51, 52

. In these cells,

activation of effector caspases requires amplification of the death signal by the mitochondrial
apoptosis pathway

	
  

53, 54

. In this scenario, proteolytic activation of BID to truncated BID (tBID) by

8

caspase-8 results in MOM permeabilization, releasing cytochrome c and Smac/DIABLO, which
respectively induces apoptosome formation and neutralizes XIAP, thus leading to effector
caspase activation

52-55

. Importantly, the level of XIAP expression has been shown to be a critical
52

determinant of whether a cell is Type I versus Type II . In that study, hepatocytes in the liver of
Bid

-/-

mice, which do not engage the mitochondrial pathway downstream of DISC and are thus
56

resistant to apoptosis induced by injection of FasL , were rendered sensitive by combined loss of
52

both Bid and XIAP .

The BCL-2 family
The identification of the BCL-2 (B-cell lymphoma 2) proto-oncogene at the chromosomal
breakpoint of t(14;18) in human follicular B-cell lymphoma resulted not only in the establishment
of the BCL-2 family of proteins, which constitute a critical intracellular checkpoint in intrinsic
1

apoptosis, but also created a new paradigm in cancer biology . All oncogenes discovered prior to
BCL-2 promoted tumorigenesis by increasing cell growth and proliferation. However, the t(14;18)
translocation, in which the immunoglobulin heavy chain promoter and enhancer drive BCL-2
57

overexpression, did not increase proliferation but rather rendered cells resistant to apoptosis .
The oncogenic potential of BCL-2 was demonstrated by Stanley J. Korsmeyer and colleagues in
two landmark studies published in 1989 and 1991 using the BCL-2-Ig transgenic mice, which
carry a minigene that structurally mimics the t(14;18)

58,59

. In humans, follicular lymphoma is often

an indolent disease comprised of small resting B cells that frequently progresses to high-grade
lymphoma. Similarly, in the 1989 study, the investigators reported that BCL-2-Ig mice developed
polyclonal follicular hyperplasia of resting B cells. In that study, the investigators also reported the
important observation that the BCL-2-Ig transgene endowed mature B cells with a prominent
survival advantage when grown in vitro in simple liquid culture. In their subsequent 1991 study,
the investigators reported that in the BCL-2-Ig mice, B cell polyclonal follicular hyperplasia
progressed to high-grade monoclonal lymphoma following a long latency period, reflecting the
clinical couse of human follicular lymphoma. The latency period preceding the appearance of
monoclonal disease indicated to the investigators that secondary changes were responsible for
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the progression from hyperplasia to lymphoma. Indeed, half of the high-grade lymphomas
harbored rearrangement of c-Myc, a proto-oncogene that drives cell growth and proliferation, and
which had been shown to synergize with BCL-2 in vitro. In summarizing their findings, the authors
proposed BCL-2 to be the founding member of a novel category of proto-oncogenes that drive
tumorigenesis not by promoting growth and proliferation, but rather by functioning “as an antidote
against death”. And indeed, the evasion of cell death has been proven to be a hallmark of cancer
60

progression .
The BCL-2 family contains approximately 20 proteins and is divided into three subfamilies
based on their death regulatory activity and homology shared within four conserved BCL-2
61

homology domains (BH1-4) . The anti-apoptotic members include BCL-2, BCL-XL, and MCL-1.
Pro-apoptotics are further divided into multidomain members BAX and BAK, and a diverse group
of BH3-only members. Studies from our lab have further defined two groups of BH3-only
molecules: ones that directly activate BAX/BAK and ones that indirectly activate BAX/BAK
62

through inactivating BCL-2/BCL-XL/MCL-1 . Upon apoptosis, the “activator” BH3-only molecules
(BH3s), including tBID, BIM, and PUMA, trigger homo-oligomerization of BAX and BAK to
mediate cytochrome c efflux, leading to caspase activation. Conversely, the anti-apoptotic BCL2/BCL-XL/MCL-1 sequester activator BH3s into inert complexes, thus preventing the activation of
BAX/BAK. The remaining BH3s including BAD, NOXA, BMF, HRK, and BIK/BLK do not activate
BAX and BAK directly, but instead prevent the anti-apoptotic BCL-2 members from sequestering
the activator BH3s. Thus, the inactivator BH3s can displace activator BH3s from anti-apoptotics
to activate BAX and BAK indirectly. The data from this study established a hierarchical regulation
of mitochondrion-dependent apoptosis by BCL-2 subfamilies (Fig. 1.2). In the absence of death
stimuli, BAX and BAK are both inactive monomers, with BAX in the cytosol and BAK in the
61

mitochondrial outer membrane (MOM) . Mitochondrial BAK is kept in an inactive conformation
63

through its association with the MOM protein VDAC2 . Once activated, BAX inserts into the
MOM as homo-oligomers while BAK also homo-oligomerizes, leading to MOM permeabilization,
release of cytochrome c from the intermembrane space (IMS), and apoptosome formation
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61, 64

.

Targeted gene deletion has demonstrated that BAX and BAK constitute the essential
65

gateway to mitochondrial apoptosis . Unlike the stable and ubiquitously-expressed BAX and
BAK, a third pro-apoptotic multidomain BCL-2 family member, BOK, is labile with prominent
expression restricted to the reproductive organs and is therefore not essential for cytochrome c
66

release . The functional redundancy of BAX and BAK is apparent when comparing the mild
phenotypes of Bax
67

-/-

mice and Bak

-/-

mice with the severe phenotype of mice deficient for both

-/-

-/-

Bax and Bak . Bak mice have no overt phenotype while the Bax mice displays mild lymphoid
-/-

hyperplasia and male sterility due to defective sperm-cell differentiation. However, most Bax Bak
/-

-

mice die perinatally with fewer than 10% surviving to adulthood. The exact cause of perinatal
-/-

-/-

lethality of the Bax Bak mice is still unknown. The surviving mice demonstrated developmental
defects including persistence of interdigital webs, an imperforate vaginal canal, and accumulation
of excess cells in the central nervous and hematopoietic systems. Importantly, the elimination of
interdigital webs during the formation of digits in higher vertebrates via programmed cell death is
a well-described example of its role in tissue remodeling

68

and was completely rescued by just

one wild-type Bax or Bak allele. Furthermore, neither intrinsic death signals nor overexpression of
BH3-only molecules were able to induce cytochrome c release and apoptotic death in cells
deficient for both Bax and Bak

65, 69, 70

.

The nature of the cytochrome c-releasing pore formed by the BAX and BAK homooligomeric complexes on the MOM is still under investigation. Much more is known about the
molecular mechanisms governing BAX and BAK activation, a tightly regulated process mediated
by dynamic interactions with activator BH3-only molecules. For both BAX and BAK, activation
means that these normally inactive, monomeric proteins undergo conformation changes and
homo- oligomerization

61, 71

. While BAK always resides in the MOM, BAX is mostly cytosolic with a

small fraction loosely associated with the mitochondria

61, 64

. Therefore, unlike BAK, BAX

activation requires the additional step of mitochondrial translocation. The insertion of BAX and
BAK into the MOM is mediated by its C-terminal α9 helix

61, 72

. Our lab found that for BAX, in the

absence of death signals, the N-terminal α1 helix stabilizes the α9 in the dimerization pocket
64

formed by the BH1-3 domains, thus preventing BAX mitochondrial targeting . In the presence of
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upstream death signals, activator BH3-only molecules tBID, BIM, and PUMA transiently bind the
α1 helix to drive N- and C-terminal exposure, thereby freeing the α9 helix for MOM insertion.
tBID, BIM, and PUMA then drive the homo-oligomerization of mitochondrially-localized BAX. The
α1 helix of BAK is always exposed, thus allowing it to be constitutively targeted to the MOM
where it is kept inactive through binding with the MOM protein VDAC2 via its dimerization pocket.
Death signals induce activator BH3-only molecules to disrupt the inhibitory BAK-VDAC2
interaction to enable BAK homo-oligomerization. The essential role of the activator BH3-only
molecules in directly activating BAX and BAK was clearly demonstrated by our studies on
73

-/-

-/-

knockout mice deficient for Bid, Bim, and PUMA . The Bid Bim PUMA
-/-

-/-

mice displayed the

-/-

same developmental defects associated with Bax Bak mice, including interdigital webbing and
imperforate vaginas. Furthermore, despite the presence of other BH3-only molecules, combined
deficiency of Bid, Bim, and PUMA prevented BAX and BAK homo-oligomerization, cytochrome c
release, and caspase activation in response to intrinsic death signals in neurons and T
lymphocytes.

Regulation of the BCL-2 family by life and death signals
Given its central role in the regulation of apoptosis, the BCL-2 family is understandably
under tight control by both pro-death and pro-survival signals at the transcriptional and post61

transcriptional level . The ratio between pro- and antiapoptotic BCL-2 family members
1

constitutes a rheostat that sets the threshold of susceptibility to apoptosis . Pro-death signals shift
the ratio to favor BAX/BAK activation while pro-survival signals do the opposite. For example,
following death receptor ligation and DISC formation, inactive cytosolic BID is proteolytically
converted by caspase-8 to the active, mitochondrially targeted tBID

53, 54

. Cleavage of BID by

caspase-8 results in its N-myristoylation via a newly-exposed glycine, thus driving its
translocation to the MOM. Additionally, genotoxic stress upregulates the pro-apoptotic BH3-only
molecules NOXA and PUMA via the transcription factor p53

74-76

. Endoplasmic reticulum (ER)

stress activates the transcription of BIM via the transcription factor CHOP and induces
dephosphorylation of BIM through PP2A, which prevents its ubiquitination and proteasomal
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77

degradation . Furthermore, in lymphocytes, cytokine withdrawal and subsequent shutdown of the
pro-survival PI3K/AKT pathway leads to BIM induction via activation of the transcription factor
78

FOXO3A . On the other hand, in the presence of growth factors, BIM phosphorylation by ERK1/2
79

disrupts its ability to bind BAX . ERK1/2 phosphorylation of human BIM at Ser69 also promotes
its subsequent phosphorylation by Rsk1/2, which mediates its binding to the E3 ligase SCFβ

TrCP

80

leading to its ubiquitination and proteasomal degradation .
Antiapoptotic BCL-2 family members are similarly regulated both transcriptionally and
post-transcriptionally by pro-death and pro-survival signals. BCL-XL is transcriptionally induced via
81

the JAK-STAT pathway following the activation of cytokine receptors . Furthermore, upregulation
of BCL-XL by the transcription factor NF-kB mediates the pro-survival effects of CD28 costimulation during T cell receptor (TCR) activation in T lymphocytes

82, 83

and of CD40 activation in

84

B lymphocytes . Post-transcriptional regulation of antiapoptotic BCL-2 family members is
exemplified by MCL-1. Due to the presence of a PEST region upstream of its BH3 domain, MCL1 protein is more labile than BCL-2 and BCL-XL and is rapidly downregulated during apoptosis,
suggesting it is important in rapidly shifting the threshold of susceptibility to apoptosis in response
85

to acute environmental changes . Upon DNA damage, the HECT-domain-containing E3 ubiquitin
86

ligase MULE ubiquitinates MCL-1, leading to its proteosomal degradation . Furthermore, DNA
87

damage and cytokine withdrawal result in phosphorylation of MCL-1 by the kinase GSK-3 .
Phosphorylated MCL-1 is then ubiquitinated and targeted to the proteosome by the E3 ligase
SCFβ

TrCP

. GSK-mediated MCL-1 phosphorylation also targets it for polyubiquitination and

degradation by the tumor suppressor E3 ubiquitin ligase SCF

FBW7

, indicating that the loss of

FBW7 observed in diverse human cancers may contribute the tumorigenesis through
88

upregulation of MCL-1 expression . Finally, during mitotic arrest induced by antitubulin
chemotherapeutic agents, MCL-1 is phosphorylated by GSK-3 and subsequently ubiquitinated
and targeted for proteasomal degradation by the tumor suppressor E3 ubiquitin ligase SCF

FBW7 89

.

In contrast, stabilization of MCL-1 and consequent promotion of cell survival is mediated by the
90

deubiquitinase USP9X, which directly interacts with and deubiquitinates MCL-1 . Interestingly,
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the same study demonstrated that expression levels of MCL-1, which is known to be abnormally
high in a range of human cancers, directly correlates with USP9X expression in human tumors.

Caspase-independent cell death
Even in the absence of caspase activation, the induction of BAX and BAK homooligomerization by activator BH3-only molecules has lethal consequences for the cell due to
mitochondrial dysfunction

69, 91

. Indeed, mitochondrial outer membrane permeabilization (MOMP)

is generally considered to be the “point of no return” commiting a cell to death regardless of
caspase activation. The occurrence of caspase-independent cell death (CICD) in vivo is apparent
upon comparing the phenotype of Apaf-1
-/-

-/-

and Bid Bim Puma
Apaf-1

-/-

mice

92

-/- 73

-/- 92

and Caspase-9

-/- 93

-/-

mice with that of Bax Bak

-/- 67

mice. The elimination of interdigital webs was only delayed by 2 days in

and occurred normally in Caspase-9
-/-

persisted into adulthood in both Bax Bak
-/-

neuronal cells observed in adult Bax Bak

-/-

-/-

-/-

-/-

93

mice . However, interdigital webs
-/-

and Bid Bim Puma

-/-

mice. The accumulation of

mice was likewise absent in adult mice deficient in

Apaf-1 or Caspase-9. Furthermore, deficiency in Apaf-1, Caspase-9, or Caspase-3 provides only
transient protection against death induced by BH3-only molecules despite the lack of caspase
-/-

-/-

69

activation while Bax Bak cells were completely protected .
In healthy cells, the mitochondrial inner membrane (MIM), which separates the matrix
from the intermembrane space (IMS), is highly impermeable to water and ions while the
mitochondrial outer membrane (MOM) is generally assumed to be freely permeable to small
91

metabolites and solutes up to ~5 kDa . The impermeability of the MIM allows the embedded
electron transport chain (ETC) to generate a proton gradient across the membrane, which forms
94

the basis of the inner mitochondrial transmembrane potential (ΔΨm) . This electrochemical
gradient is positively charged and acidic on the side facing the IMS and negatively charged and
alkaline on the matrix-facing side. The proton gradient is used by the ATP synthase enzyme
complex, located in the MIM, to generate ATP from ADP and is also used by ion-exhange
channels to regulate mitochondrial ion homeostasis. The ΔΨm set up by the proton gradient is
also required for protein import into the mitochondrial matrix since it both activates the inner
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membrane protein import channel and drives positively charged presequences into the matrix.
Accordingly, the loss of ΔΨm that occurs following MOMP leads to loss of ATP production, ion
91

homeostasis, and mitochondrial protein import . Mitochondrial dysfunction induced by BAX/BAK
activation can be caspase dependent or independent. Caspase-3 can cleave the p75 subunit of
95

the complex I of the electron transport chain, leading to loss of ΔΨm . The molecular
mechanisms underlying caspase-independent mitochondrial dysfunction are still unclear.
Although release of cytochrome c, a component of the ETC, may be expected to inhibit ETC
activity thus leading to loss of ΔΨm, there is evidence that the concentration of cytochrome c in
96

the IMS following MOMP is sufficient for ETC function . ΔΨm has also been suggested to result
from inactivation of ETC enzymes by cytosolic enzymes that are activated and/or gain entry to the
IMS following MOMP. In support of this, one study showed the caspase-independent loss of
97

activity of ETC complexes I and IV following MOMP . Mitochondrial protein import is also actively
shut down following MOMP due to degradation of TIM23, an essential component of the inner
98

membrane protein import machinery, leading to a loss of cell viability .
The release of IMS proteins AIF, Endo G, and HtrA2/Omi following MOMP has also been
91

implicated in CICD . AIF is a phylogenetically conserved flavoprotein with NADH oxidase activity
99

shown to be involved in the assembly and maintenance of Complex I of the ETC . Following
MOMP, AIF translocates into the nucleus and mediates chromatin condensation and large-scale
DNA fragmentation

100

. Loss of AIF also impairs oxidative phosphorylation due to a decrease in
99

ETC complex I activity . Likewise, Endo G, the predominant mitochondrial endonuclease
proposed to mediate mitochondrial biogenesis and DNA synthesis and repair, also translocates to
47

the nucleus following MOMP where it has been shown to degrade chromatin . HtrA2/Omi is a
serine protease that can both mediate caspase-dependent cell death via inhibitory interactions
50

with IAPs and through caspase-independent mechanisms that depend on it proteolytic activity .
Evidence indicate that loss of HtrA2/Omi is also deleterious to the mitochondria

101, 102

. Under

normal circumstances, HtrA2/Omi is proposed to mediate protein quality control in the IMS by
degrading denatured proteins. Mice bearing homozygous deletion of HtrA2/Omi or a point
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mutation that disrupts its protease activity die prematurely and exhibit neurodegeneration,
possibly due to mitochondrial dysfunction.

1.3 Autophagy
Macroautophagy, referred to from here on out as autophagy, is an evolutionarily
conserved process in eukaryotes by which proteins, organelles, and cytoplasmic content are
sequestered by double-membrane vesicles, termed autophagosomes, and delivered to
lysosomes for degradation

103

. Basal, constitutive autophagy maintains cellular homeostasis by

mediating the elimination and recycling of old or damaged organelles as well as turnover of longlived proteins and protein aggregates

103

. Autophagy is also a survival response stimulated by

multiple forms of cellular stress such as nutrient depletion, hypoxia, damaged organelles, and
pathogen invasion

104

. One of the most important roles for autophagy is to provide energy for vital

cellular functions via digestion of the cell’s own contents

104

. Autophagic cell death (ACD) is

morphologically defined as cell death accompanied by prominent vacuolization of the cytoplasm
5

due to large-scale autophagosome formation . Although the bulk of the evidence indicates that
autophagy primarily promotes cell survival, it is conceivable that excessive autophagy can
ultimately lead to cellular demise. However, it remains unclear whether there are regulatory
mechanisms that specifically activate autophagy to execute cell death.

Core mammalian autophagy machinery
Although the molecular control of autophagy was initially investigated in yeast, the
process of autophagy is largely conserved between yeast and mammals

103

. Figure 1.3 depicts a

simplified schematic of mammalian autophagosome formation. The first step of mammalian
autophagy is autophagosome nucleation, in which a small, flat, crescent-shaped organelle termed
the phagophore or isolation membrane is nucleated by core components of the autophagosome
machinery. The isolation membrane then elongates and expands around cytoplasmic contents
until a double-membraned autophagosome is formed upon complete envelopment of a portion of
the cytoplasm or damaged organelles. Studies have shown that membrane components required
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to form the autophagosome membrane can originate from the mitochondria outer membrane
and the endoplasmic reticulum

106

105

. The autophagosome then fuses with the lysosome to form the

autophagosome, where the inner membrane of the autophagosome and its cargo of cytoplasmderived material are then degraded by lysosomal hydrolases. Monomeric units such as amino
acids generated by the degradation of macromolecules are then exported to the cytosol for reuse
through permeases that are still poorly characterized. At the peak of autophagy a large
percentage of lysosomes may be subsumed into autophagosomes and that, upon cessation of
autophagy, proto-lysosomal membrane components are recycled via tubules and vesicles to form
new lysosomes
The

107

.

mechanism

of

autophagosome

formation

requires

a

highly

orchestrated,

evolutionarily-conserved series of events that are still being elucidated. Nutrient depletion is the
most typical and potent inducer of autophagy

104

. Briefly, the unc-51-like kinase (ULK) complexes

are apical inducers of autophagosome formation that, upon nutrient depletion, are activated and
localize at the phagophore

108,

109

. Nucleation, and also subsequent maturation of the

autophagosome, requires the VPS34 class III phosphatidylinositol-3 kinase (PI3K)-Beclin 1
complexes

110-113

. Beclin 1 plays an important role in tumorigenesis that will be discussed in more

detail in a later section

110

. The PI3K complex generates phosphatidylinositol 3-phosphate

(PtdIns(3)P) in the phagophore membrane, an event required for recruitment of other
components of the autophagy machinery

103

. Phagophore elongation and closure requires the

Atg12 and Atg8/LC3 ubiquitin-like protein conjugation systems

103, 114

. Atg12 is conjugated to Atg5

in a reaction mediated by the E1-like enzyme Atg7 and the E2-like enzyme Atg10, which then
interacts with Atg16 to form the large multimeric Atg16L complex on the cytoplasmic side of the
phagophore membrane

103

. C-terminal cleavage of Atg8/LC3 by Atg4 generates LC3-I, which is

conjugated to phosphatidylethanolamine (PE) to generate LC3-II on the phagophore membrane
in an Atg7- and Atg3-dependent manner where it mediates membrane tethering and
hemifusion

103,114

. The transmembrane protein Atg9 shuttles between the phagophore and

peripheral sites to presumably deliver membranes to the developing phagophore, and does so in
an ULK- and class III PI3K-dependent manner
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. VMP1, another transmembrane autophagy

protein, is required for autophagy induced by nutrient depletion, a function that depends on its
interaction with Beclin 1

116

. This sugests VMP1 may recruit class III PI3K-Beclin 1 complexes to

the phagophore. Upon completion, the proteins that mediate autophagosome formation are
released back to the cytoplasm through an unknown mechanism.

Autophagy as part of the cellular stress response
Autophagy is activated by diverse stresses including nutrient depletion, ER stress, and
microbial infection or exposure to microbial products

104

. Of these, nutrient depletion is the most

typical, best characterized, and most potent trigger of autophagy, which can be induced by lack of
any essential nutrient

117

. Thus, while autophagy is most potently induced in yeast by nitrogen

starvation, the withdrawal of carbon, auxotrophic amino acids and nucleic acids, and sulfate can
all initiate autophagy

117

. Cultured mammalian cells similarly induce autophagy upon withdrawal of

amino acids and glucose

117

. For metazoans, though, it is important to note that autophagy is not

simply the response of an individual cell to nutrient depletion, but is also a crucial part of an
organism’s response to starvation

117,118

. Therefore, autophagy is also controlled by extracellular

growth factors and by the hormones insulin and glucagon

117, 118

. Indeed, one of the earliest

observations of autophagy, made in 1962 prior even to the coining of the word, was in the
hepatocytes of rats that had been exposed to glucagon, a hormone induced during times of
fasting

119

. Insulin, which is induced during and immediately following a meal, was later shown to

inhibit autophagy

119

. One of the most striking demonstrations of the importance of autophagy at

the organismal level is the phenotype of mice deficient for the genes Atg5

120

or Atg7

121

, which are

essential for autophagosome formation. Although developmentally normal, they have a mortality
rate of >90% within the first 24 period following delivery likely due to an inability to use autophagy
to bridge over the starvation period between cessation of trans-placental nutrient supply and
onset of suckling. One of the main purposes of autophagy during starvation is to maintain both
intracellular and extracellular amino acid levels, both of which decrease in autophagy-deficient
mice subjected to starvation

120

. The amino acids thus produced may help organisms survive

starvation by driving hepatic gluconeogenesis, in which lactate and amino acids from peripheral
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tissues are used by the liver via the glucose-alanine cycle to produce glucose to compensate for
depletion of glycogen stores during prolonged starvation

117

. Furthermore, amino acids can also

be used to produce oxidizable substrates for energy production via the tricarboxylic acid (TCA)
cycle

117

.
The

autophagy

104

mTOR

pathway

is

the

best-characterized

regulator

of

starvation-induced

. mTOR is a serine/threonine kinase and as a component of mTOR complex 1

(mTORC1) is central in growth factor signalling and nutrient- and energy-sensing pathways

104

. Its

activation increases protein synthesis and overall cell growth when metabolic conditions are
favorable and/or when stimulated by growth factors

104

. In mammalian cells, the first clue that

mTOR suppresses autophagy was the observation that the mTOR inhibitor rapamycin induces
autophagy in isolated rat hepatocytes

122

. Though the mechanism by which mTOR regulates

autophagy is still an active area of investigation, mTOR-mediated inhibition of the ULK complex is
central to this process

103, 108

.

Sirtuins, NAD-dependent deacetylases that sense environmental stress, have also been
implicated to play a crucial role in starvation-induced autophagy

104

. Evidence indicates central

roles for sirtuins in regulating metabolism and aging-related physiological changes, and that the
mammalian sirtuin SIRT1 mediates the lifespan-extending effects of calorie restriction

123

.

Overexpression of SIRT1 was found capable of inducing autophagy while genetic deletion of Sirt1
impaired autophagy activation in mouse embryonic fibroblasts

124

. In that study, SIRT1 was

demonstrated to regulate the acetylation status of the core autophagy regulators Atg5, Atg7, and
LC3. Furthermore, decreased association between the sirtuin SIRT2 and the transcription factor
FoxO1 following serum starvation in human cancer cell lines leads to FoxO1 acetylation

125

.

Acetylated FoxO1 in the cytosol then binds with Atg7 to promote autophagosome formation.

Autophagy as a cellular housekeeper
Autophagy is not only induced as part of a cell’s integrated response to stress, but also
functions at a basal level as a “cellular housekeeper” that eliminates defective proteins and
organelles and prevents the accumulation of abnormal protein aggregates
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103

. These

“housekeeping” functions are viewed as central to the protective role of autophagy observed in
neurodegenerative diseases and cancer

126

. Mice bearing tissue-specific deletions of Atg5 and

Atg7 demonstrate an accumulation of protein aggregates in inclusion bodies associated with
cellular degeneration in post-mitotic hepatocytes, cardiomyocytes, and neurons

126

. Additionally,

Atg7-deficient mouse hepatocytes accumulate peroxisomes, damage mitochondria, and aberrant
membranous structures contiguous with the ER

121, 127

. Since mitochondrial damage can lead to its

overproduction of reactive oxygen species (ROS), some of the pro-survival effects of mitophagy
have been attributed to the removal of this potential source of oxidative damage

126

. Similarly,

peroxisomes generate ROS through their metabolic functions, necessitating turnover of the
organelle due to oxidative damage of its constituents

128

.

A key feature of many neurodegenerative diseases is the formation of intracellular
aggregates

129

. These include Parkinson’s disease, polyglutamine expansion diseases such as

Huntington’s disease, and forms of dementia. Early observations of autophagosomes in these
disease settings suggested involvement of autophagy in disease pathogenesis. However, model
organisms have shown that autophagosome formation is either part of a protective response or,
in the case of Alzheimer’s disease, a consequence of impaired autophagosome maturation

126

.

For example, mutations of the dynein motor machinery found in human neurodegenerative motor
neuron diseases were found to reduce the clearance of aggregate-prone proteins and enhance
the toxicity of the causative agent of Huntington’s disease, the mutant huntingtin protein, due to
impairment of autophagosome-lysosome fusion

130

. Furthermore, the mTOR inhibitor rapamycin

reduces mutant huntingtin toxicity in vitro and in vivo via induction of autophagy

131

.

Selective autophagic removal of damaged mitochondria, or mitophagy, is of particular
interest within the context of cell death since loss of ΔΨm, which occurs following induction of
MOMP by diverse death signals, targets mitochondria for mitophagy

132

. A pro-survival role for

mitophagy in this context has been proposed based on the finding that the glycolytic enzyme
GAPDH promotes clonogenic survival following MOMP partly due to a novel ability to enhance
autophagy via Atg12 upregulation

133

. The recognition and targeting of depolarized mitochondria

for autophagic removal is mediated by the kinase PINK1 and the E3 ligase Parkin
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132, 134-136

. When

mitochondria are healthy, PINK1 translocates into the mitochondrial inner membrane via the
general mitochondrial import machinery composed of the TOM and TIM23 complexes. There, it
undergoes cleavage by the protease PARL, leading to its destabilization and degradation.
However, since its import into the inner membrane and subsequent degradation relies on the
mitochondrial membrane potential, loss of ΔΨm leads to rapid accumulation of PINK1 on the
mitochondrial outer membrane and recruitment of the E3 ubiquitin ligase Parkin in a manner
dependent on PINK1 kinase activity. Parkin recruitment to the MOM leads to ubiquitination of
MOM substrates including VDAC1, and recruits the autophagy adaptor molecule p62/SQSTM1 to
initiate mitophagy. Parkin and PINK1 mutations are implicated in the neurodegenerative disorder
Parkinson’s disease, in which mitochondrial dysfunction is believed to play a casual role

137

.

Autophagy as a tumor suppressor mechanism
Impaired autophagy has also been demonstrated to promote tumorigenesis, possibly
through promoting genomic instability and inappropriate cell division

126

. The involvement of the

autophagy machinery in cancer was initially revealed by the discovery in 1999 that beclin 1,
mono-allelically deleted in 40-75% of sporadic human breast and ovarian cancers, is a candidate
tumor suppressor
cell line

110

. In that study, the enforced expression of Beclin 1 in a human breast cancer

promoted

autophagy, inhibited

proliferation

and

clonogenicity, and

impaired

tumorigenesis in nude mice. Furthermore, the expression of endogenous Beclin 1 is lower in
human breast carcinoma tissue compared to normal mammary epithelia. Subsequent generation
of beclin 1 deficient mice revealed that homozygous loss of beclin 1 causes early embryonic
lethality while heterozygous loss results in a high incidence of spontaneous tumors

138

. Loss of the

second beclin 1 allele is not observed in these tumors, indicating that Beclin-1 is a
haploinsufficient tumor suppressor. Though beclin 1 was initially discovered during the positional
cloning of BRCA1, it was rediscovered independently in a yeast two-hybrid screen for interaction
partners of BCL-2

139

. Importantly, ER-localized BCL-2, which is often overexpressed in cancers,

can inhibit autophagy by binding to Beclin 1 via the Beclin 1 BH3 domain
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140

.

Autophagy as a cell death mechanism
One of the first in vitro demonstrations that autophagy could indeed be a cell death
mechanism appeared in 2004 with the report that RNAi-mediated knockdown of the essential
autophagy regulators Beclin 1 and Atg7 protects against RIP1-dependent non-apoptotic death
induced by caspase-8 inhibition in vitro

141

. That same year, another group reported that

-/-

-/-

knockdown of Beclin 1 or Atg5 protects Bax Bak mouse embryonic fibroblasts against intrinsic
death signals that induced extensive autophagy

142

. Then in 2007, the finding that degradation of

larval salivary glands during Drosophila melanogaster metamorphosis depends on autophagy
provided the first in vivo evidence that it may be a cell death mechanism

143

. In that study,

autophagy inhibition via transgenic expression of autophagy inhibitory molecules or removal of
autophagy genes results in the persistence of salivary gland cell fragments. Yet, autophagy does
not account for all the processes of this developmental death. First, autophagy inhibition only
delays tissue degradation by ~24 hours. Also, only the disappearance of cell fragments and not of
whole intact cells is delayed.
Due to its ability to degrade large portions of the cytoplasm, excessive activation of
autophagy can be expected to cause cellular demise. Indeed, expression of Beclin-1 mutants that
cannot be regulated by BCL-2 can kill cultured mammalian cells in vitro

140

while transgenic

expression in D. melanogaster larvae of a highly active mutant Atg1, an ortholog of mammalian
ULKs, results in premature salivary gland degradation in vivo

144

. Yet, the in vivo evidence that cell

death in a mammalian model organism is executed specifically by autophagy versus by another
cell death modality is poor. For example, death induced by the hyperactive Atg1 mutant in D.
melanogaster larvae is caspase-dependent and shows the morphological features of apoptosis,
leading the authors to suggest that excessive autophagy is an inducer of apoptosis rather than a
distinct form of cell death

144

. Although neuron-specific genetic deletion of Atg7 has been shown to

protect against cell death in a mouse stroke model, the mode of death blocked by Atg7 loss in
this scenario likewise displayed characteristic features of apoptosis

145

. This suggests that Atg7 is

not killing via autophagy; rather, it is activating an apoptotic program either via autophagy or
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another upstream mechanism. Therefore, it is still controversial whether autophagy does indeed
constitute a cell death mechanism distinct from apoptosis and necrosis.
1.4 Necrosis
Programmed necrotic death: a new cell death paradigm
In their seminal report in 1972, Kerr and colleagues explained that they are coining a new
term, “apoptosis”, in order to distinguish an apparently physiologically regulated form of cell death
that had until then been called “necrobiosis” or “shrinkage necrosis” from “necrosis” or
13

“coagulative necrosis”, which was widely regraded as accidental and unregulated . Although it
was acknowledged that there must exist a programmed form of cell death to counterbalance cell
proliferation during development and in the adult, the morphological type of cell death described
13

in almost all standard texts at the time was necrosis . At that time, investigators believed that
necrosis could not be responsible for physiological cell death as it always appeared to be caused
13

by an irreversible disturbance of cellular homeostasis due to exposure to noxious stimuli . And
indeed, until the late 1980s, there was scant evidence to suggest otherwise.
In 1988, the observation that the death receptor ligand tumor necrosis factor (TNF) can
induce either apoptosis or necrosis in vitro depending on the cell type provided the first clue that
8

necrosis may also be subjected to molecular control . Subsequent studies demonstrated that the
necrotic response to TNF is mediated by increased generation of reactive oxygen species (ROS)
by the mitochondria, in part due to increased glutamine metabolism that resulted in increased
eletron flux through the mitochondrial electron transport chain

146-148

. A significant step in

determining the mechanism of death receptor-induced necrosis was achieved with the finding that
caspase inhibition switches the response of death receptor ligation from apoptosis to necrosis
150

149,

. Then in 2000, details of the mechanisms regulating death receptor-induced necrosis began to

emerge with the finding that necrosis triggered by the Fas death receptor ligand FasL requires its
adaptor protein FADD and the enzymatic activity of the serine-threonine kinase RIP1

151

. The

same study found that necrosis induced by the death receptor ligands TNF and TRAIL also
require RIP1 kinase activity. The central role of the kinase activity of RIP1 in death receptorinduced necrosis was demonstrated by the 2008 finding that it is the target of necrostatin-1 (nec-
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1)

152

, a potent and specific small molecule inhibitor previously discovered in 1995 by the same

investigators to inhibit TNF-induced necrosis in vitro
was named “necroptosis” by these researchers

153

153

. This type of regulated necrotic cell death

. In the 1995 report, nec-1 was also shown to

protect against cerebral necrosis following ischemia-reperfusion in an in vivo stroke model

153

. In

that same year, which proved to be a particularly fruitful one for the concept of a regulated form of
necrosis, three groups independently reported that genetic deletion of Cyclophilin D, a key
component of the mitochondrial permeability transition pore that leads to mitochondrial
dysfunction and cell death following prolonged calcium overload, protects against necrosis
following tissue ischemia-reperfusion in vivo and to specifically protect against necrosis but not
apoptosis in vitro

154-156

. Thus, in less than two decades, programmed necrosis went from being a

poorly-recognized biological phenomenon to a genetically regulated, physiologically relevant cell
death subroutine.
Though sometimes used to indicate programmed necrosis in general, “necroptosis” is
defined biochemically as a type of cell death inhibitable by genetic or pharmacological ablation of
the kinase activity of RIP1 and its interaction partner RIP3, and is primarily triggered by death
10

receptor activation . Reports from our lab and others also indicate the existence of RIP1- and
RIP3-independent programmed necrosis elicited by intrinsic death stimuli including genotoxic
9

stress , oxidative stress

157

, and calcium dysregulation

157

. Unlike apoptosis, a linear pathway
10

linking upstream death signals to downstream death effectors has not been established . Indeed,
physico-chemical stresses can serve as both necrosis initiators and effectors due to amplification
by positive feedback loops generated by their deleterious effects on cellular physiology in general
and on mitochondrial and lysosomal function in particular

7, 10

. Though these downstream death

execution events are still an active area of investigation, ATP depletion, oxidative damage,
dysregulated intracellular calcium homeostasis, non-caspase proteases, phospholipases, and
lipoxygenases have all been implicated.

Necroptosis
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RIP1 is a member of the RIP family of serine-threonine kinases involved in innate and
adaptive immunity and has both a kinase-dependent function in promoting apoptosis
necrosis
159, 160

151, 152

158

and

, and a kinase-independent function in promoting cell survival and inflammation

152,

. It consists of an N-terminal kinase domain, a RIP homotypic interaction motif (RHIM), and

a C-terminal death domain (DD)

160

. Ligation of the TNFR1 receptor induces a conformational

change in the preformed trimeric receptor complex, leading to recruitment of the adaptor protein
TRADD, which in turn recruits RIP1, the E3 ligases cIAP1 and cIAP2, TRAF2, and TRAF5; this
constitutes the pro-survival complex I

161

. RIP1 is polyubiquitinated by cIAP1 and cIAP2, enabling

it to act as a scaffold for assembling the TAK1-TAB2-TAB3 complex that initiates the canonical
activation

pathway

of

the

pro-survival,

pro-inflammatory

transcription

factor

NF-κB

162

.

Internalization of the ligand-bound TNFR1 and deubiquitination of RIP1 by the deubiquitinase
CYLD

158

changes the membrane-associated complex I into the cytosolic complex II consisting of

RIP1, TRADD, FADD, and caspase-8
groups to also include RIP3
induced apoptosis

158

163-165

161

. Complex II was later discovered independently by three

. Importantly, although RIP1 kinase activity mediates both TNF-

and necrosis

151

, RIP3 kinase activity is only required for necrosis

163

.

Activation of caspase-8 in this complex proteolytically inactivates RIP1 and RIP3 and initiates
apoptosis

166, 167

. In the absence of caspase-8 activity, mutual RIP1 and RIP3 phosphorylation

leads to the formation of the necrosome that constitutes the necroptosis activation complex

160, 164

.

Although altered mitochondrial metabolism and excessive mitochondrial ROS production
has been implicated in TNF-induced necrosis since the mid-1990s

146-148

, the nature and

regulation of these and potentially other lethal events downstream of the necrosome remain
poorly characterized. In line with previous findings implicating the mitochondria, RIP3 was
reported to mediate TNF-induced necrosis by increasing mitochondrial ROS generation via
upregulation of mitochondrial oxidative metabolism. Then in early 2012, a mechanistic
breakthrough was revealed by two simultaneous reports from the laboratory of Xiaodong Wang
that confirmed a central role for the mitochondria in necroptosis execution

157, 168

. In the first report,

chemical library screening identified a compound named necrosulfonamide (NSA) that blocked
necroptosis downstream of the necrosome
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. NSA functions in this context by disrupting the

25

direct interaction between RIP3 and a novel binding partner, mixed lineage kinase domain-like
protein (MLKL), via covalent modification of a MLKL cysteine residue. Following initiation of
necroptosis, phosphorylated RIP3 recruits and phosphorylates MLKL, an event shown to be
crucial for RIP3-mediated necrosis. In the second report, the authors show that MLKL, which
does not possess enzymatic activity, acts as an adaptor protein to tether the necrosome to a
splice variant of phosphoglycerate mutase 5 (PGAM5S) on the mitochondrial outer membrane via
the other PGAM5 splice variant PGAM5L

157

. Once formed, the necrosome-PGAM5S complex

drives mitochondrial fragmentation, an event implicated in cell death, through activation of an
essential mediator mitochondrial fission, the GTPase Drp1. Activation of the PGAM5S-Drp1
complex was proposed to constitute necroptosis complex III, which the authors described as a
“mitochondrial attack complex”. Interestingly, complex III but not the necrosome was shown to be
required for necrosis induced by dysregulated calcium homeostasis and ROS, raising the
possibility that this complex and the induction of mitochondrial fission may be a central
convergence point for both extrinsic (death receptor-mediated) and intrinsic necrotic signals.

Programmed necrosis initiated by physico-chemical stress
In 1997, genetic deletion of the mammalian DNA damage repair enzyme poly(ADPribose) polymerase 1 (PARP1) was reported to protect mice against cerebral ischemiareperfusion injury, providing another example of genetic regulation of necrosis in vivo

169

.

Ischemia-reperfusion injury is an important clinical problem in which necrosis caused by loss of
blood supply (ischemia) during a heart attack or stroke, or during solid organ transplantation, is
exacerbated by the restoration of blood flow (reperfusion). PARP1 catalyzes the synthesis of
poly(ADP-ribose) polymers on histones and other chromatin-associated proteins near DNA
adducts to promote efficient recognition of damage DNA by repair machinery

170

. Overactivation of
+

PARP1 consumes its substrate β-nicotinamide adenine dinucleotide (NAD ) leading to a
+

depletion of cytosolic NAD and ATP levels

170

. Activation of PARP1 by ischemia-reperfusion has

been attributed to oxidative DNA damage induced by the overproduction of ROS observed under
this setting
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. In a subsequent study, the same group demonstrated that DNA alkylation and

26

excitotoxicity induces PARP1-mediated mitochondrial dysfunction and caspase-independent cell
death mediated by the release of AIF from the mitochondria
-/-

apoptosis-incompetent Bax Bak

-/-

171

. Importantly, a 2004 study using

cells demonstrated that following DNA alkylation-induced

+

PARP1 activation and NAD depletion, cells that primarily used oxidative phosphorylation for ATP
production are protected against ATP depletion and necrosis while those that derive ATP
predominantly from glycolysis are sensitive
glycolysis

for

phosphorylation

ATP
173

production

even

172

. Importantly, since cancer cells prefer to use

when

conditions

are

permissible

for

oxidative

, this findings suggests the clinical efficacy of DNA alkylating chemotherapeutic

agents may be due in part to tumor-specific induction of necrosis

172

.

The opening of the mitochondrial permeability transition pore (MPTP) is also implicated in
the initiation of programmed necrosis triggered by oxidative stress, calcium overload, and
91

ischemia-reperfusion injury . Mitochondrial permeability transition describes the sudden increase
in permeability of the mitochondrial inner membrane (MIM) to solutes with molecular mass up to
91

1.5 kDa . This is caused by the opening of the MPTP, a multicomponent complex spanning the
91

mitochondrial outer membrane (MOM) and the MIM at the membrane contact sites . Following
opening of the MPTP, the osmotic pressure of the matrix leads to an influx of water and solutes,
91

resulting in matrix swelling . Since the surface area of the involuted MIM exceeds that of the
MOM, matrix swelling can rupture the MOM

174

, which releases cytotoxic proteins from the IMS,
91

causes mitochondrial dysfunction, and commits the cell to die .
The key factor responsible for MPTP opening is a large increase in mitochondrial matrix
91

calcium concentration, with ROS also implicated to play an important role . Mitochondrial
calcium overload and excessive ROS production are both central to necrosis following ischemiareperfusion and are both a result of ATP depletion secondary to ischemia

175

. The MPTP pore has

been proposed to consist of the voltage dependent anion channel (VDAC 1, 2, and 3) in the
MOM, the adenine nucleotide translocase (ANT1 and 2) in the MIM, and cyclophilin D (CypD) in
6

the mitrochondrial matrix . Of these, only CypD has been shown to be an indispensible
component of the MPTP. Three groups independently reported in 2005 that necrosis of neuronal
and myocardial tissue caused by ischemia-reperfusion injury in the brain and heart can be
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inhibited by genetic deletion of Ppif, the CypD-encoding gene

154-156

. In vitro experiments from

those same studies showed that loss of CypD dramatically increased the level of calcium required
to trigger MPTP opening. Significantly, though CypD was shown to be critical for necrosis, its
deficiency did not impair the induction of apoptosis. In contrast, both VDACs and ANTs are not
essential components of the MPTP. Mouse hepatocytes lacking both ANT isoforms displayed
only a small increase in the level of calcium needed to trigger permeability transition

176

while

mouse fibroblasts deficient for all three VDAC isoforms showed no protection against calciumand oxidative stress-induced MPTP opening and death

177

. Indeed, instead of showing resistance

against intrinsic death signals, cells deficient for VDAC2 are more sensitive to cell death due to its
inhibitory role in BAX activation

178

.

Finally, our lab reported in 2009 that DNA double-strand breaks induced by
-/-

topoisomerase inhibitors in apoptosis-defective Bax Bak

-/-

double knockout mouse embryonic

fibroblasts (MEFs) trigger programmed necrosis in a RIP1-, PARP1, and CypD-independent
9

manner . We demonstrated that inhibition of transcription and translation protected against death,
indicating that the initiation and execution of necrosis in this setting requires de novo gene
expression. Furthermore, our study revealed that p53-mediated induction of the lysosomal
protease cathepsin Q cooperated with increased production of ROS to execute necrosis.

Executioner mechanisms of necrosis
It is currently unclear whether diverse death signals induce programmed necrosis via a
10

common, well-defined sequence of executioner mechanisms . Indeed, even in the case of the
best characterized programmed necrosis pathway, necroptosis, the sequence of events leading
from necrosome formation to eventual death is unclear. Nevertheless, most instances of
programmed necrosis involve some or all of the following: ROS; mitochondrial and lysosomal
dysfunction; dysregulated intracellular calcium homeostasis; and the activation of non-caspase
proteases and phospholipases

7, 10

. Increasing evidence indicate that mitochondrial damage and

dysfunction, induced either directly (e.g. by oxidative damage) or indirectly (e.g. calcium overload
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secondary to energy depletion, as in the case of ischemia-reperfusion), also play central roles in
the execution of programmed necrosis under diverse settings

7, 91, 179

.

Excessive mitochondrial ROS production and consequent oxidative damage is a central
7

execution mechanism of programmed necrosis . ROS are derivatives of molecular oxygen that
are produced during normal physiological processes such as fatty acid catabolism and aerobic
respiration

180

. Under healthy states, endogenous ROS production is countered by cellular

antioxidant defences

180

. Excessive ROS production and/or impaired antioxidant capacity

generates a deleterious state of oxidative stress, which damage all cellular constituents

180

. In

most scenarios, intracellular ROS is primarily produced by the mitochondrial electron transport
chain (ETC) as the unavoidable byproduct of aerobic respiration

181

. The leakage of electrons

passing through the ETC leads to the one-electron reduction of O2 to O2
can then give rise to other ROS such as the hydroxyl radical

181

•—

(superoxide), which

. Oxidative stress may contribute

to cellular demise through, for example, inducing autocatalytic lipid peroxidation

180

. Among the

ROS, superoxide and the hydroxyl radical are common initiators of this process, in which
unsaturated membrane lipids are converted into polar lipid hydroperoxides

180

. This increases

membrane fluidity, damages membrane-associated proteins, and compromises membrane
integrity

180

. Compromised lysosomal membrane integrity can lead to the harmful release of

lysosomal proteases while damage to the ER membrane can result in a deleterious release of ER
calcium

179

. With regard to proteins, oxidative damage can not only alter or abolish their functions

but in some cases can also lead to increased ROS production

180

. For proteins containing iron-

sulfur (Fe-S) clusters, oxidative denaturation of the clusters can release redox-active ferrous iron
into the cellular environment

180

. There, ferrous iron can catalyze the decomposition of hydrogen

peroxide, which is poorly reactive, into the highly reactive hydroxyl radical, which can readily
damage all nearby cellular constituents

180

. This decomposition of hydrogen peroxide is known as

the Fenton reaction. In the case of the ETC, oxidative damage sustained by its components can
increase electron leakage, creating a vicious cycle of ROS generation and oxidative damage

181

.

In pathological settings, elevated cellular calcium levels can contribute to necrosis though
triggering mitochondrial membrane permeability transition as previously described, but also by
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inducing ROS production, mitochondrial fragmentation, calcium-dependent calpain protease
7

activation, and cytosolic phospholipase A2 (cPLA2) translocation . In a normal, resting state, the
concentration of free calcium in the cytosol and the mitochondrial matrix is ~ 10-100 nM; in
contrast the ER calcium concentration is ~ 100-500 µM while that of the extracellular environment
is in the mM range

182, 183

cytosol and mitochondria

. This enables calcium to function as a second messenger in both the

182

. The maintenance of these steep concentration gradients depends on

plasma and ER membrane ATPase transporters (respectively, plasma membrane Ca
or PMCA, and sarco/endoplasmic reticulum Ca
sodium-Ca

2+

2+

2+

ATPase

ATPase or SERCA), the plasma membrane

exhanger (NCX), and on the integrity of cellular membranes

182

. Therefore, ATP

depletion and oxidative damage sustained by cellular membranes, such as that seen during
ischemia-reperfusion, can dramatically increase cytosolic and mitochondrial matrix calcium levels.
The mitochondrial inner membrane potential drives calcium into the matrix through a
highly selective inner membrane Ca

2+

channel

182

. Under physiological conditions, upon ER

2+

calcium release, matrix [Ca ] can reach several hundred µM while cytosolic levels can only reach
1-2 µM

183

. Thus, mitochondria can buffer cytosolic calcium and tolerate a significant rise in matrix

2+

[Ca ] before underoing permeability transition. Increased mitochondrial matrix calcium
concentration upregulates the TCA cycle, leading to increased electron flow into the mitochondrial
ETC and thus increased ROS production

182

. Pathological rises in calcium can lead to excessive

ROS production, leading to oxidative stress. This is the main mechanism proposed for calciuminduced mitochondrial ROS overproduction during programmed necrosis

179

. Interestingly, there

are hints at another, non-mutually exclusive mechanism. Mitochondria are highly dynamic
organelles that can build interconnected networks that continuously move along cytoskeletal
tracks and frequently undergo fusion and fission

184

. Fusion and fission machinery shape the

mitochondrial compartment in response to ever-changing physiological conditions

184

. The Drp1

GTPas is a master regulator of mitochondrial fission and can be activated to promote fission by
2+

2+

elevated cytosolic [Ca ] via phosphorylation by Ca /calmodulin-dependent protein kinase Iα
(CaMKIα) at serine 600

185

and dephosphorylation by calcineurin at serine 637

186

. Increased

mitochondrial fission has been shown to mediate increased ROS production following exposure
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to hyperglycemia in vitro, though the mechanism is unclear

187

. Importantly, activation of Drp1 by

death receptor ligation, elevated calcium levels, and oxidative stress has been implicated in the
execution of programmed necrosis

157

2+

. This suggests elevated cytosolic [Ca ] may also induce

excessive ROS production as well as other potentially deleterious events during programmed
necrosis through promoting mitochondria fission.
Calpains are ubiquitously and constitutively expressed cytosolic cysteine proteases
7

activated by an increase in cytosolic calcium concentration . Overactivation of calpains can result
+

in proteolysis of the plasma membrane Na /Ca

2+

exchange pump involved in extrusion of calcium
7

from the cytosol, thus further disrupting cellular calcium homeostasis . Calpain overactivation has
also been proposed to disrupt lysosomal membranes, leading to lysosomal membrane
permeabilization (LMP) and the attendant deleterious release of lysosomal cathepsin proteases
7

into the cytosol . Significantly, following ischemic injury, activated µ-calpain was observed to
localize at the membranes of damaged lysosomes in monkey hippocampal neurons

188

.

Furthermore, cathepsin inhibitors were able to protect these neurons from ischemia-induced
death

189

.
Increased cytosolic calcium concentration also promotes translocation of cPLA2 to the

nuclear, ER, and Golgi appartus membrane where it hydrolyzes arachidonate-containing
7

phospholipids to release arachidonic acid . Both free and esterified arachidonic acid are
substrates for lipoxygenases that convert them into lipid hydroperoxides. Lipid hydroperoxidation,
which can also occur via oxidative damage as described previously, compromises organelle and
plasma membrane integrity. cPLA2 activation is implicated in TNF-induced necrosis while its
7

deficiency has been reported to protect against brain ischemia .
Finally, lysosomes and cathepsins are also implicated in programmed necrosis. The
“calpain-cathepsin” hypothesis has been previously discussed, as has data from our lab
implicating cathepsin Q in executing DNA damage-induced programmed necrosis. Under normal
conditions, the lysosome is also the sole intracellular location of redox-active ferrous iron before it
is incorporated into the catalytic center of proteins or stored as ferritin

179

. Hydrogen peroxide can

readily cross cellular membranes to enter the lysosome and generate hydroxyl radicals via the
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Fenton reaction
peroxide

179

179

. Importantly, the lysosome does not possess enzymes that detoxify hydrogen

. Involvement of lysosomal iron in necrosis is indicated by the ability of intralysosomal

iron chelators to protect against oxidative stress-induced LMP and cell death.

Physiological and pathological roles of programmed necrosis
Loss of function animals models have demonstrated the importance of key regulators of
programmed necrosis in promoting tissue injury under diverse pathological conditions. Although
-/-

Rip1 mice are not viable

190

and tissue-specific knockout and kinase-dead knock-in have not yet

been reported, its role in brain ischemia

153

, myocardial infarction

191

, and head trauma

192

are

-/-

indicated by the protective effects of necrostatin-1 administration in those scenarios . Rip3 mice
are viable and protected from pancreatic acinar cell necrosis in a rodent acute pancreatitis
model

163

. PARP1 loss also protects against acute pancreatitis

193

tissue infarction in mouse models of stroke and myocardial infarction

while loss of CypD reduces
154-156

.

Though necrosis was traditionally viewed as a pathological form of cell death, the
observation that naturally occuring motor neuron death may exhibit necrotic features provided an
early indication that necrosis may also constitute a physiological cell death mechanism

194

. Then

in 2011, three key reports provided evidence suggesting a physiological role for necroptosis
during development as well as giving an answer to a conundrum in the cell death field

195-197

. The

extrinsic pathway of apoptosis is initiated by the binding of a death ligand to its cognate plasma
membrane death receptor, leading to the formation of the death-inducing signalling complex
(DISC) previously discussed, with FADD, caspase-8, and the caspase-like regulator molecule
FLIP all being components of this complex. Knockout of any of these three molecules results in
embryonic lethality, with a failure in yolk sac vascularization and hematopoiesis

198-200

. It is difficult

to attribute this phenotype to a defect in apoptosis, which typically leads to defects associated
-/-

with excessive cells such as those seen with the Bax Bak

-/-65

-/-

-/-

and Bid Bim PUMA

-/-73

mice. In

2011, three independent groups of investigators showed that combined genetic deletion of
caspase-8 and RIP3

195, 196

or of FADD and RIP1

197

results in normal embryonic development,

indicating that the developmental defects and embryonic lethality caused by loss of FADD and
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caspase-8 are due to a failure to suppress necroptosis. Furthermore, one of those groups also
used RNAi-mediated knockdown of FLIP in Caspase-8 and Rip3 doubly-deficient mouse
embryonic fibroblasts to demonstrate that a caspase-8-FLIP heterodimer inhibits RIP3-dependent
necrosis

196

.

It is currently unclear how an organism may benefit from being able to readily trigger
-/-

necroptosis during development or adult life. Rip3 mice develop into healthy and fertile adults

201

,

indicating that organisms can develop and live successfully without a functional necrosome. Still,
the fact that there exists a molecular mechanism to suppress necroptosis during normal
embryonic development suggests necroptosis may play roles that are essential for the welfare of
the organism under specific, possibly adverse settings. The effect of necrotic death versus
apoptosis on the immune system suggests one possible physiological function. With few
exceptions, apoptosis in vivo is anti-inflammatory and produces immunological tolerance whereas
necrosis triggers inflammation and an immune response

179

. Both apoptotic and necrotic cell

corpses are efficiently cleared from surrounding tissue by professional and non-professional
phagocytes. However, in the case of necrosis, the lack of organized chromatin condensation and
loss of cellular membrane integrity results in leakage of pro-inflammatory factors (e.g. histones,
the chromatin-associated protein HMGB1, DNA, and RNA) that are detected by and activate
immune cells. This suggests that a cell may prefer a necrotic death in settings where an
inflammatory response may be beneficial to the organism, such as in cases of pathogenic
infection. In support of this, viral infections are known to initiate necroptosis

179

. For example,

vaccinia virus infection induces the formation of the pro-necrotic RIP1-RIP3 complex
sensitizes cells to TNF-induced death in a RIP1-dependent manner

202

164

and

. Accordingly, RIP3-

deficient mice are resistant to vaccinia virus-induced hepatic inflammation and necrosis, but
cannot effectively control viral replication

164

. Furthermore, the murine cytomegalovirus protein

M45 disrupts RIP1-RIP3 interaction to inhibit necroptosis

203,204

. Importantly, viral infection of wild-

type mice is severely attenuated by a mutant M45 that cannot interact with RIP1-RIP3.
Importantly, attentuation of viral infection is completely rescued in RIP3-deficient mice

204

. In

aggregate, these studies demonstrate that viruses utilize inhibition of host cell necrosis as a
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strategy to sustain viral replication, whereas host cells undergo necrosis as a way to clear viral
infection.

1.5 Significance
The past few decades have witnessed a paradigm shift in the field of cell death. The idea
that apoptosis is the only form of programmed cell death has been challenged by the emerging
evidence that necrosis can be as programmed as apoptosis. Characterization of pathways that
initiate programmed necrosis is well under way while animal models are providing increasing
insights into the physiological and pathological roles of programmed necrosis. Although the
events and processes that ultimately result in cellular demise and the mechanisms of their
activation by upstream death initiation events are unclear, these are also beginning to be
elucidated. Whether diverse necrotic signals converge on a single sequence and set of execution
mechanisms remains to be determined. Given the wide variety of pathologies in which
programmed necrosis is implicated, a thorough understanding of the factors that influence the
outcome of the life-or-death decision upon exposure to death stimuli can potentially open up
broad new avenues for therpeutic intervention for many human injuries and diseases. Importantly,
the evasion of apoptosis is a key hallmark of tumorigenesis; thus, delineation of programmed
necrosis pathways and the factors that may contribute to resisting necrotic death will provide new
strategies for the treatment of human cancers.
Oxidative stress is central to both the initiation and execution of programmed necrosis. In
Chapter Two, I demonstrated that the transcription factor ΔNp63α protected against programmed
necrotic death (PND) and enhanced long-term survival of apoptosis-defective cells in the face of
intrinsic death signals via a previously unknown ability to control intracellular redox homeostasis
by regulating glutathione metabolism. My findings from Chapter Two also established oxidative
stress as a central determinant of death versus long-term survival following exposure to intrinsic
death signals. In Chapter Three, I showed that in DKO MEFs, DSBs trigger an ATM/ATR/DNAPK-mediated DNA damage response that increased ROS production by upregulating the activity
of complex III of the electron transport chain.
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1.6 Figure Legends

Figure 1.1 Cell death is categorized according to morphological features. Electron microscopy
images of a normal (a), autophagic (b), apoptotic (c), and necrotic (d) cell. Scale bar = 1 µm.
(Figure adapted from Edinger et al., (2004) Curr Opin Cell Biol. 16: 663-669)

Figure 1.2 Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies.
(Figure adapted from Kim et al., (2006) Nat. Cell Biol. 8, 1348-58)

Figure 1.3 Schematic depiction of the autophagy pathway and its core molecular machinery in
mammalian cells. (Figure adapted from Yang et al., (2010) Curr Opin Cell Biol. 22:124-131)
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664 Cell division, growth and death

1.7 Figures
Figure 1.1 Morphological features of apoptosis, autophagy, and necrosis

Figure 1

et al.,
Curr
Opin Cell
Biol. 16:(d)663-669
Morphological features of autophagic, apoptotic andEdinger
necrotic cells.
(a) (2004)
Normal, (b)
autophagic,
(c) apoptotic
and necrotic cells. Whereas the
morphologic features of apoptosis are well defined, the distinction between necrotic and autophagic death is less clear. The bioenergetic
catastrophe that culminates in cellular necrosis also stimulates autophagy as the cell tries to correct the decline in ATP levels by catabolizing its
constituent molecules. Thus, vacuolation of the cytoplasm is observed in both autophagic cells (b) and in cells stimulated to undergo
programmed necrosis (d). By contrast, ATP levels are maintained in normal (a) and apoptotic cells (c) consistent with the limited number of
autophagic vacuoles in their cytoplasm. The scale bar represents 1 mm.

damaged organelles and long-lived proteins in addition to
its catabolic role providing energy in times of famine. It has
been suggested that cells can die a ‘programmed’ death by
autophagy in which cells digest themselves to death as a
suicide strategy (reviewed in [8–10]). This idea is in direct
contradiction with the proven role of autophagy in many
different organisms as a survival mechanism during lean
times. Thus, the question emerges, is autophagy a survival
pathway, a suicide pathway or both in mammalian cells?
This review will discuss recent advances in our understanding of the biological relevance of programmed necrosis and the role of autophagy in determining cell fate and
will explore the idea that necrosis and autophagic death are
really two sides of the same coin.

Necrosis: not just an accident?
When caspases
were originally identified as the mediators36
	
  
of apoptosis, it was hypothesized that many of their
Current Opinion in Cell Biology 2004, 16:663–669

substrates were essential proteins whose destruction
ensured the inevitability of cell death. However, caspase-independent cell death is observed in many systems
indicating that cells still die even if the executioner is
absent. Following an apoptotic stimulus, such as the
expression of Bax or treatment with tumor necrosis factor
(TNF) or Fas ligand, cells will die even in the presence of
non-specific caspase inhibitors such as zVAD-fmk or antiapoptotic molecules like Bcl-XL that prevent caspase
activation [2,4]. Under these conditions, cells that would
normally die by apoptosis exhibit all the hallmarks of
necrosis. In some cases, caspase-independent necrotic
cell death can be forestalled by treatment with antioxidants or by eliminating the activity of the protein kinase
RIP. These results led to the idea that necrosis could be
‘programmed’ — cellular signaling events initiated necrotic destruction that could be blocked by inhibiting discrete cellular processes. A criticism of this concept of
www.sciencedirect.com
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target of rapamycin (TOR) complex 1 (TORC1). A
family of mammalian Atg1 proteins has been identified;
among these, unc-51-like kinases 1 (ULK1) and 2 have
Core molecular machinery
the highest similarity with yeast Atg1 and appear to be
ULK complexes
or ULK2
	
  
37 closely related. siRNA knockdown of ULK1
blocks autophagy in HEK293 cells [6!]. However,
The yeast serine/threonine kinase Atg1 plays a key role in
the induction of autophagy, acting downstream of the
ULK1"/" mice display normal autophagy in response
extracellular stresses relies largely on the elucidation of the
signaling network upstream of the Atg machinery.
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-CHAPTER TWO-

p63 Inhibits Oxidative Stress-Induced Cell Death by
Orchestrating Glutathione Metabolism
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2.1 Abstract
Despite the importance of ROS in executing cell death, its regulation remains elusive.
Here, we report that p63 dictates the homeostasis of intracellular redox through transcriptional
controls of glutathione metabolism genes. Overexpression of ΔNp63α, the major isoform of p63,
protected cells from oxidative stress induced by thiol or lipid oxidants, DNA damage, and anoikis.
Conversely, deficiency of ΔNp63α increased oxidative stress. Strikingly, overexpression of
-/-

-/-

ΔNp63α rendered clonogenic survival of p53 Bax Bak

-/-

triple-knockout cells against DNA

damage. Along the same line, co-expression of BCL-2 and ΔNp63α, which abrogated apoptosis
and oxidative stress, respectively, produced clonogenic survival against matrix detachment and
disrupted the luminal clearance of mammary acini. In conclusion, inhibiting apoptosis only offers
short-term survival, whereas a simultaneous blockade of apoptosis and oxidative stress is central
for long-term survival.

2.2 Introduction
Proper execution of cell death ensures normal biological processes, and its deregulation
1

causes human illness, ranging from cancer to neurodegenerative disorders . Three forms of cell
death have been recognized based on morphological features: apoptosis, autophagic cell death,
2

and necrosis . Among the three distinct forms of cell death, apoptosis is best studied. The BCL-2
3

family proteins are central regulators of apoptosis . Genetic loss-of-function studies reveal an
essential axis of upstream “activator” BH3-only molecules and downstream BAX and BAK in
4-7

activating mitochondrion-dependent apoptosis . In response to apoptotic signals, the “activator”
BH3-only molecules, including BID, BIM, and PUMA, trigger the homo-oligomerization of
multidomain proapoptotic BAX and BAK to permeabilize mitochondria, leading to the efflux of
cytochrome c which in turn initiates the assembly of apoptosome complex for caspase activation
10

5-

. Although apoptosis has long been considered as the major cell death mechanism required for
2

the successful development and maintenance of tissue homeostasis in metazoans , double
deficiency of Bax and Bak only disrupts the development and homeostasis in restricted sets of
4

tissues , suggesting the existence of BAX and BAK-independent cell death mechanism(s) in
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maintaining the tissue homeostatic state. To explore this cell death conundrum, we utilized
-/-

transformed Bax Bak

-/-

double-knockout (DKO) mouse embryonic fibroblasts (MEFs) and

discovered that these apoptosis-deficient cells underwent a regulated form of necrotic cell death
11

in response to DNA damage induced by topoisomerase inhibitors . Surprisingly, this type of
11

necrotic cell death requires active transcription/translation , which is in stark contrast with a
general perception that necrosis is not programmed. As this DNA damage-induced “programmed
necrotic death” (PND) does not require RIP1, it is distinct from TNF-induced “necroptosis”

12

(fig.

S2.1). Furthermore, we have reported that this death is independent of caspases, mitochondrial
11

permeability transition pore (PTP), autophagy, or PARP . Notably, DNA alkylation induces
PARP-dependent necrotic death whereas double-strand DNA breaks induces PARP-independent
necrotic death in DKO cells

11,13

. Mechanistically, we delineated a p53-cathepsin axis that

cooperates with ROS (reactive oxygen species) to activate PND in DKO cells undergoing double11

strand DNA breaks . By analogy to DNA damage-induced cell death, it was reported that
inhibition of apoptosis by BCL-2 is insufficient to provide long-term clonogenic survival against
anoikis

14,15

, a form of cell death that is induced by detachment from extracellular matrix in

anchorage-dependent cells. Remarkably, antioxidant cooperates with BCL-2 to enhance
clonogenic survival and prevent the luminal clearance of acini in three-dimensional culture of
15

mammary epithelial cells . Thus, although apoptosis is the fastest mechanism for eliminating
cells in response to death stimuli, inhibition of apoptosis is insufficient to render long-term
clonogenic survival, which is indeed required for the prevention of pathological loss of cells during
disease processes. ROS is one of the most important second messengers in executing necrosis

16

and appears to play a critical role in abrogating long-term clonogenic survival. Despite its
essence, how ROS is regulated remains largely uncharacterized.

2.3 Results
Because our data indicated that genotoxic stress-induced necrotic death requires active
11

transcription , we hypothesized that ROS could be regulated by transcription factor(s). A series
of gain-of-function and loss-of-function screens identified p63, the primordial member of the p53

	
  

62

17

family , as a master transcriptional regulator of ROS. Overexpression of the major isoform of
p63, ΔNp63α, prevented etoposide-induced ROS accumulation in transformed DKO MEFs (Fig.
2.1A). Three ROS-sensitive dyes were employed to interrogate intracellular ROS levels—
H2DCFDA, a broad-spectrum ROS indicator; dihydroethidium (DHE), a specific indicator for
superoxide; and MitoSOX Red, a specific indicator for mitochondrial matrix superoxide as
mitochondria are the major source of ROS within the cells

16,18

. Consistent with our previous
11

identification of p53 and ROS as two independent effectors in executing necrotic death ,
overexpression of a dominant negative mutant of p53 (p53 DN) failed to block ROS induction
triggered by genotoxic stress (Fig. 2.1 A). Overexpression of either ΔNp63α or p53 DN provided
DKO cells a short-term survival advantage against etoposide (Fig. 2.1 B). Importantly, coexpression of both ΔNp63α and p53 DN enhanced clonogenic survival of DKO cells against
etoposide (Fig. 2.1 C). To further demonstrate p53-independent regulation of ROS by ΔNp63α,
-/-

-/-

-/-

-/-

-/-

-/-

p53 Bax Bak triple-knockout (TKO) MEFs were generated. Transformed p53 Bax Bak TKO
-/-

MEFs were more resistant to DNA damage than Bax Bak

-/-

DKO MEFs (fig. S2.2). However,

TKO cells were eventually killed by DNA damage due to ROS-induced oxidative stress that was
abrogated by antioxidant N-acetyl-L-cysteine (NAC) or diphenyleneiodonium (DPI) (fig. S2.3).
Strikingly, overexpression of ΔNp63α protected TKO from etoposide-induced ROS accumulation
and cell death (Fig. 2.1, D to F, and fig. S2.4). It was reported that another p63 isoform, TAp63, is
induced by DNA damage in MEFs

19

and deficiency of TAp63 but not p53 protects oocytes from
20

ionizing irradiation-induced cell death . Of note, we could only detect TAp63 but not ΔNp63 in
MEFs by PCR (fig. S2.5). In fact, the level of TAp63 in MEFs was too low to be detected by
immunoblots. Knockdown of TAp63 in DKO or TKO MEFs had no effect on etoposide-induced
cell death (fig. S2.5), indicating that endogenous TAp63 is not involved in DNA damage-induced
necrotic death and ΔNp63α does not inhibit oxidative stress through antagonizing endogenous
TAp63. In summary, our gain-of-function approach discovered a previously unrecognized role of
ΔNp63α in regulating oxidative stress. Moreover, the inhibition of oxidative stress by ΔNp63α
-/-

-/-

-/-

rendered clonogenic survival of p53 Bax Bak TKO cells against DNA damage.
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Oxidative stress is caused by an imbalance between the production of ROS and the
ability of detoxifying reactive intermediates

16,21

. If ΔNp63α prevents DNA damage-induced

oxidative stress by increasing antioxidant capacity, ΔNp63α should also protect cells against
exogenous oxidants. Indeed, overexpression of ΔNp63α protected wild-type cells from thiol
oxidant diamide and lipid oxidant tert-butyl hydroperoxide (TBH) (Fig. 2.2A). These findings are
consistent with a notion that ΔNp63α alters the intracellular redox state by increasing the
antioxidant capacity of cells and thereby protects cells against diverse sources of oxidative stress.
Given that glutathione is the major antioxidant produced by the cell and plays a central role in
regulating intracellular redox state

16,21,22

, one testable thesis is that ΔNp63α mitigates oxidative

stress through transcriptional regulation of glutathione metabolism genes. Glutathione is
synthesized in two sequential steps, catalyzed by glutamate-cysteine ligase (GCL) and
glutathione synthetase (GSS), respectively

22

(Fig. 2.2B). It exists in both reduced (GSH) and

22

oxidized (GSSG) states . GSH can act as a free radical scavenger and an inhibitor of lipid
peroxidation. GSH also participates in the detoxification of hydrogen peroxide through various
glutathione peroxidases (GPX) (Fig. 2.2B). During this process, GSH is oxidized to GSSG, which
can then be recycled back to GSH through the action of glutathione reductase (GSR) at the
expense of reduced nicotinamide adenine dinucleotide phosphate (NADPH). NADPH can be
generated by several enzymes, including isocitrate dehydrogenase 2 (IDH2). Interestingly, gene
expression profiling revealed that genes involved in glutathione redox pathway were upregulated
in ΔNp63α-overexpressing cells both before and after DNA damage (fig. S2.6). Quantitative RTPCR analysis confirmed that GCLC (the catalytic subunit of GCL), GSS, IDH2, and GPX2 were
upregulated by ΔNp63α (Fig. 2.2C). Hence, it appears that DNp63a orchestrates a genetic
program to integrate the biosynthesis of glutathione, the utilization of GSH as an antioxidant, and
the regeneration of GSH from GSSG (Fig. 2.2B), the outcome of which would increase the ratio of
GSH to GSSG, an indicator of a more reduced intracellular redox state. Indeed, overexpression
of ΔNp63α significantly increased the GSH/GSSG ratio in cells both before and after etoposide
treatment (Fig. 2.2D). The functional significance of these ΔNp63α-induced glutathione
metabolism genes in regulating necrotic cell death was interrogated by siRNA-mediated
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knockdown (fig. S2.7). Deficiency of GCLC, GSS, GPX2, or IDH2 compromised, to varying
extents, the ability of ΔNp63α to protect DKO cells against DNA damage (Fig. 2.2, E to H). Of
note, deficiency of these genes also enhanced etoposide-induced cell death in control DKO cells,
but to a lesser degree (Fig. 2.2, E to H), supporting the involvement of oxidative stress in this
form of cell death. Collectively, our data demonstrate that p63 orchestrates a tightly coupled
glutathione metabolic circuit to alleviate oxidative stress and thereby protects apoptosis-defective
cells from ROS-mediated necrotic cell death (Fig. 2.2B).
To investigate the role of endogenous ΔNp63α in regulating redox homeostasis,
knockdown of p63 using a published shRNA

23

was performed in cell lines where ΔNp63α is the

predominant isoform (Fig. 2.3A). In agreement with our gain-of-function study, knockdown of
endogenous ΔNp63α led to increased intracellular ROS levels in both human mammary epithelial
cell line MCF-10A and human cervical carcinoma cell line ME-180 (Fig. 2.3B). Furthermore,
knockdown of p63 using siRNA or miR30-based shRNA also increased ROS in these cells (Fig.
S2.8). Importantly, quantitative RT-PCR demonstrated that deficiency of ΔNp63α downregulated
GCLC, GSS, IDH2, and GPX2 (Fig. 2.3C)—the same set of genes that was upregulated by
ΔNp63α (Fig. 2.2C). Of note, GSR was suppressed by the loss of endogenous ΔNp63α but not
induced by the overexpression of ΔNp63α (Fig. 2.3C and data not shown), which might reflect
cell type-specific regulation. Consistent with the downregulation of glutathione metabolism genes
caused by the knockdown of ΔNp63α, the GSH/GSSG ratio was reduced in cells deficient for
ΔNp63α (Fig. 2.3D), indicating a more oxidized intracellular redox state. Consequently, deficiency
of ΔNp63α enhanced diamide-induced cell death, which was protected by the antioxidant NAC
(Fig. 2.3E). Furthermore, deficiency of ΔNp63α sensitized cells to chemotherapeutic agentinduced cell death (fig. S2.9). Altogether, our loss-of-function studies demonstrate an important
role of endogenous ΔNp63α in gauging redox homeostasis.
The observation that antioxidant and anti-apoptotic BCL-2 work in concert to promote
long-term clonogenic survival against matrix detachment

15

prompted us to investigate whether

p63 can mitigate oxidative stress associated with anoikis and whether p63 can cooperate with
BCL-2 to prevent the luminal clearance of acini in three-dimensional culture of MCF-10A cells.
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Overexpression of ΔNp63α protected MCF-10A cells from anoikis, but to a lesser degree than
BCL-2 (Fig. 2.4A). Importantly, overexpression of ΔNp63α but not BCL-2 prevented ROS
induction in cells undergoing anoikis (Fig. 2.4B). Because BCL-2 profoundly blocked anoikis up to
5 days, the combined effect of BCL-2 and ΔNp63α was not evident in short-term death assays
(Fig. 2.4A). To investigate long-term survival in response to the loss of matrix attachment, MCF10A cells were seeded onto reconstituted basement membrane under conditions that enable the
formation of three-dimensional acini where the inner, matrix-deprived cells are eliminated to
facilitate lumen formation

14,15

. Overexpression of either BCL-2 or ΔNp63α only weakly whereas

co-expression of BCL-2 and ΔNp63α markedly inhibited luminal clearance (Fig. 2.4, C and D).
Luminal clearance of MCF-10A acini was evident within two weeks after seeding, whereas coexpression of BCL-2 and ΔNp63α near completely blocked luminal clearance for up to a month
(Fig. 2.4, C and D). Importantly, overexpression of ΔNp63α but not BCL-2 suppressed ROS
accumulation in the matrix-deprived luminal cells (Fig. 2.4E).
We presented evidence that ΔNp63α enhances endogenous antioxidant capacity through
a coordinated regulation of glutathione metabolism genes. Among these identified ΔNp63α
24

targets, GPX2 is the only reported direct transcriptional target of ΔNp63α . It is conceivable that
ΔNp63α may regulate the remaining targets directly or indirectly. Since Nrf2 is the most
recognized transcription factor that controls the expression of many antioxidant genes, including
GCLC

25,26

, and Nrf2 mRNA was slightly induced by ΔNp63α (fig. S2.10), we investigated whether

ΔNp63α regulates GCLC through Nrf2 and whether Nrf2 is required for the antioxidant effect of
ΔNp63α. Although knockdown of Nrf2 partially reduced GCLC (fig. S2.10), ΔNp63α-mediated
upregulation of GCLC was not affected by the loss of Nrf2 (fig. S2.10). Accordingly, the protective
effect of ΔNp63α against DNA damage-induced necrotic death was not affected by the deficiency
of Nrf2 (fig. S2.10). These data not only illustrate an Nrf2-independent regulation of GCLC by
ΔNp63α but also indicate that ΔNp63α is a bona fide central regulator of glutathione biogenesis. It
remains to be determined how ΔNp63α integrates the glutathione metabolic program.
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2.4 Discussion
Here, we report that ΔNp63α prevents oxidative stress and cooperates with apoptotic
inhibition to promote long-term cellular survival against DNA damage and extracellular matrix
detachment, highlighting the quintessence of suppressing oxidative stress in promoting long-term
survival. Foreseeably, inhibition of oxidative stress may be especially critical to the wellbeing of
long-lived cells such as stem cells. Notably, ΔNp63α is important in maintaining the stem cell
populations of stratified epithelia

17,27

. In addition to sustaining the proliferative capacity of

27

epithelial stem cells , ΔNp63α may also promote stem cell survival through its antioxidant
function. p63

+/-

mice have a shortened life span and display features of accelerated aging, and
28

p63-deficient cells exhibit heightened cellular senescence , all of which could be caused by
oxidative damage

18

and may be linked to oxidative stress resulted from the loss of ΔNp63α. In

contrast to the tumor suppressor function of p53, ΔNp63α has been implicated as an oncogene
and is frequently amplified and/or overexpressed in human squamous cell carcinoma of the lung
and head and neck

17,29

. Because cancers often have an increased demand for antioxidant

capacity compared to normal tissues likely due to inherent metabolic derangements that increase
21

ROS production , the Nrf2 antioxidant program has thus been shown to contribute to
30

tumorigenesis . By analogy, ΔNp63α might promote tumorigenesis by reducing oxidative stress.
Although a detailed blueprint of the core apoptotic pathway has been formulated through
biochemical and genetic studies over the past two decades, we are still unable to fully rescue
cells from most death stimuli. The identification of oxidative stress as a critical mechanism
compromising long-term survival of apoptosis-defective cells likely open new avenues for the
therapeutic intervention aimed at preventing cellular loss during pathological processes.
Conversely, targeting the antioxidant pathway may hold promise for the future development of
anticancer therapeutics to eliminate cancer cells that evade apoptotic checkpoints.
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2.5 Materials and Methods
Plasmid construction, retrovirus production, and siRNA
Murine ΔNp63α was dually tagged with FLAG and HA at the N-terminus and cloned into MSCVIRES-Puro or tagged with HA at the N-terminus and cloned into MSCV-IRES-GFP. A dominant
negative mutant of p53 (aa 1-14 and aa 303-390) was dually tagged with FLAG and HA at the Nterminus and cloned into MSCV-Puro (Clontech). Human BCL-2 was cloned into MSCV-IRESGFP or MSCV-Puro. Retrovirus-mediated knockdown constructs were generated using
pSuperior-Retro-Puro according to the manufacture’s instructions (Oligoengine). The target
sequence of shRNA against mouse p63 is 5’-AGCACACGATCGAAACGTA-3’. The target
sequence of scramble shRNA is 5’- GCGCGCTTTGTAGGATTCG-3’. The production of
6

retroviruses was described previously . Lentivirus-mediated knockdown constructs for human
p63 and GFP were previously described

23, 31

. All constructs were confirmed by DNA sequencing.

Lentiviral tetracycline-inducible miR30-based shRNA against human p63 was obtained from
Open Biosystems. The target sequence is 5’-TCCGAGCTATGTCAGTACTATT-3’. To induce the
expression of shRNAmir, cells were treated with 2 µg/ml doxycycline (Sigma) for 3 days.
Lentivirus was produced by cotransfection with pCMVDR8.2 and pHCMV.VSVG using
Lipofectamine 2000 (Invitrogen). siRNA oligos were reverse-transfected using Lipofectamine

TM

RNAiMAX (Invitrogen) to a final concentration of 10 or 20 nM. The siRNA oligos were purchased
from Ambion Silencer Select oligos (Applied Biosystems) or Dharmacon: mouse IDH2 #1, 5’AGACUGACUUCGACAGGAAtt

(Ambion

s114463);

GGAAUAAGAUCUGGUAUGAtt

(Ambion

95489);

CGGUAUGACUCAAUAGAUAtt

(Ambion

s66718);

GGGUGAUCCUCUCAUACAAtt

(Ambion

s201400);

GCCCAGUCAGUAUAAUUCAtt

(Ambion

s67110);

CCAUCAAAAAGGACGACUAtt

(Ambion

s67112);

UCAAUGAGCUGCAAUGUCG

(Dharmacon

CAACUACCCGGGACUACAA

mouse

IDH2

#2,

5’-

mouse

GCLC

#1,

5’-

mouse

GCLC

#2,

5’-

GSS

#1,

5’-

GSS

#2,

5’-

GPX2

#1,

5’-

mouse
mouse
mouse

siGenome-02);

(Dharmacon

siGenome-03);

mouse

GPX2

mouse

#2

Nrf2,

5’5’-

CAUUUUUACUCAUCGAUCUtt (Ambion s70523); mouse p63, 5’-CCACCGAACUGAAGAAGCU
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(Dharmacon

siGenome-04);

human

p63,

5’-CGACAGUCUUGUACAAUUU

(Dharmacon

siGenome-08); mouse RIP1 #1, 5’-GGUGGUACCCUUUACUACAtt (Ambion s72975); mouse
RIP1 #2, 5’-GGAUUUGGAACUACAGGUAtt (Ambion s72977); Ambion Silencer Select Negative
Control #1; Dharmacon siGenome Negative Control #2.

Cell culture and viability assays
-/-

-/-

SV40-transformed Bax Bak double-knockout (DKO) mouse embryonic fibroblasts (MEFs) were
6

previously described . E1A/Ras and c-Myc/Ras transformation was performed by infecting
primary MEFs within the first 2 passages with retrovirus expressing E1A-IRES-Ras or c-MycIRES-Ras as described previously
-/-

-/-

-/-

-/-

32

. For E1A/Ras transformation, primary MEFs were generated
-/-

-/-

-/-

from E12.5 Bax Bak DKO embryos and E12.5 p53 Bax Bak triple-knockout (TKO) embryos.
-/-

E12.5 p53 Bax Bak

6

TKO MEFs were transformed with SV40 as described previously . ME-

180 and MCF-10A cell lines were obtained from ATCC and cultured according the instructions.
To induce anoikis, cells were grown on poly-HEMA (Sigma)-coated 6 well plates in the presence
of 1% methylcellulose (Sigma). Cell death was quantified by annexin-V (BioVision) or propidium
iodide (Sigma) staining, followed by flow cytometric analysis using either a FACSCalibur (BD
Biosciences) or a LSRFortessa (BD Biosciences). Data were analyzed using CellQuest Pro (BD
Biosciences) or FACSDiva (BD Biosciences). P values for statistical analysis were obtained
using Student's t test.

Measurement of ROS
Production of ROS was monitored by flow cytometric analysis using the redox-sensitive dyes.
Cells were incubated with 1 µM 2’,7’-dichlorofluorescein diacetate (H2DCFDA, Invitrogen), 1 µM
5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA, Invitrogen), or 1
µM dihydroethidium (DHE, Invitrogen) at 37°C for 30 minutes, or with 2.5 µM MitoSOX Red
(Invitrogen) at 37°C for 10 minutes. Oxidation of the ROS-sensitive dyes was quantified by flow
cytometric analysis using either a FACSCalibur (BD Biosciences) or a LSRFortessa (BD
Biosciences). Median fluorescence in the appropriate detection channels was assessed by
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FlowJo (Tree Star). Fold induction of ROS was determined by dividing the median fluorescence
of experimental samples with that of control samples. P values for statistical analysis were
obtained using Student’s t-test.

Clonogenic assays
SV40-transformed MEFs were treated with etoposide (10 µg/ml) for 14 hours. E1A/Ras- and c-/-

-/-

-/-

Myc/Ras-transformed p53 Bax Bak TKO MEFs, transduced with retrovirus expressing GFP or
GFP-IRES-ΔNp63α, were subjected to MoFlo (Beckman Coulter) sorting for GFP-positive cells
4

5

before treatment with etoposide for 9 hours. 5 x 10 or 10 cells were washed with PBS and
plated in 24-well tissue culture plates. Colonies were fixed with methanol and stained with 0.5%
crystal violet in 25% methanol after 10-12 days.

Reverse transcription and quantitative PCR
Total RNA was extracted from cells using TRIZOL (Invitrogen) according to the manufacturer’s
instructions. Reverse transcription was performed with oligo-dT plus random decamer primers
(Ambion) using Superscript II (Invitrogen). Quantitative PCR was performed with SYBR green
master mix (Applied Biosystems) in duplicates using the indicated gene specific primers. For
TaqMan probes, quantitative PCR was performed with TaqMan PCR Master Mix (Applied
Biosystems). Quantitative PCR was performed on an ABI Prism 7300 sequence detection system
(Applied Biosystems) or a ViiA 7 Real-Time PCR System (Applied Biosystems). Data were
analyzed as described previously by normalization against GAPDH or 18S rRNA that was
11

detected using TaqMan probes (Applied Biosystems) . Primers for qRT-PCR are listed as
follows:

mouse

p63

pan-isoform,

5’-

GTTTCTGAAGTAGGTGCTGGTGCT-3’;
CCTATATGCTCAGTACAGCCCATCG-3’
mouse

p63

∆N

isoform,

5’-

CCTTTCCGTCAGAATACACACGGA-3’
mouse
and

5’-

p63

TA

and

isoform,

5’5’-

CTATTCTGTGCGTGGTCTGTGTTGT-3’;

TCTTAGAAGATTCGCAGCGCAAGG-3’

and

5’-

CTATTCTGTGCGTGGTCTGTGTTGT-3’; mouse GCLC, 5’-TACACCTGGATGATGCCAACGA-3’
and 3’-GTCAACCTTGGACAGCGGAATG; mouse GSS, 5’-CCTGATGCTAGAGAGATCTCGTGC
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and 3’-CTCTCTCCTCACTGTCCTTCAGC; mouse IDH2, 5’-CCTGATGACATCTGTGCTGGTCT
and 3’-GAGCTCTGTCCAGGTTGCTCTT; human GSS, 5'-GACCAGCGTGCCATAGAGAATGA
and

3’-CATGTGACCTCTCCAGCAGTAGAC;

human

IDH2,

5’-

GATGGGAAGACGATTGAGGCTGA and 3’-TCAGGAAGTGCTCGTTCAGCTT; human GPX2, 5'TCTATGACCTCAGTGCCATCAGC and 3'-CCAGGACGGACATACTTGAGACTG; human GSR,
5'-CCAACGTCAAAGGCATCTATGCAG and 3'-ATCTTCCGTGAGTCCCACTGTC; mouse Nrf2,
5’-ATCCAGACAGACACCAGTGGATC-3’

and

5’-CAAACTTGCTCCATGTCCTGCTC-3’.

The

TaqMan probes for mouse GPX2 (TaqMan Assay ID Mm00850074_g1) and human GCLC
(TaqMan Assay ID Hs00155249_m1) were obtained from Invitrogen.

Three-dimensional culture of MCF-10A and indirect immunofluorescence microscopy
MCF-10A cells were seeded onto reconstituted basement membrane (Matrigel) under conditions
that enable formation of three-dimensional acini and were then assessed by indirect
immunofluorescence microscopy as previously described

33, 34

4

. Briefly, 10 cells were seeded onto

one chamber of a 4-well chamber slide pre-coated with Matrigel (BD Biosciences). After 31 days,
cells were fixed using 4% paraformaldehyde (Fisher) and permeabilized using 0.5% Triton X-100,
and sequentially incubated with anti-Laminin-5 (D4B5, EMD Millipore), Alexa Fluor 568
conjugated goat anti-mouse IgG (Invitrogen), anti-GFP (ab13970, Abcam), Alexa Fluor 488
conjugated goat anti-chicken IgG (Invitrogen), and nuclear stain 4,6-diamidino-2-phenylindole
(DAPI, Sigma). Images were acquired using the Leica TCS SP5-II Confocal Upright and the
PerkinElmer UltraVIEW ERS confocal microscopes at the Molecular Cytology Core Facility at the
Memorial Sloan-Kettering Cancer Center and analyzed by MetaMorph software (Molecular
Devices). Cellularity of the equitorial cross-sections was scored as clear (~0-25% of the luminal
space filled with cell nuclei), mostly clear (~25-50% cellularity), mostly filled (~50-75% cellularity),
and filled (~75-100% cellularity). To measure ROS levels, three-dimensional culture of MCF-10A
cells after 6-8 days were incubated with Hank’s Balanced Salt Solution (HBSS, Invitrogen)
containing 5 µM dihydroethidium (DHE, Invitrogen) and 3 µg/ml Hoechst 33342 (Invitrogen) at
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37°C for 30 minutes in a humidified 5% CO2 incubator, washed once with HBSS, then
immediately imaged using the Leica TCS SP5-II confocal microscope.
Reagents, antibodies, and immunoblot analysis
Chemicals used are listed as follows: etoposide (Sigma), diamide (Sigma), tert-butyl
hydroperoxide (Sigma), diphenyleneiodonium (Sigma), doxorubicin (Sigma), cisplatin (Sigma),
and N-acetyl-L-cysteine (Sigma). Antibodies used for immunoblot analysis are listed as follows:
anti-FLAG (M2, Sigma), anti-p53 (FL393, Santa Cruz Biotechnology), anti-p63 (4A4, Santa Cruz
Biotechnology), anti-GCLC (HPA036359, Sigma), anti-IDH2 (ab55271, Abcam), anti-RIP
(610458, BD Biosciences), and anti-β-actin (A1978, Sigma). Cell lysates were resolved by 10% or
4-12% NuPAGE gels (Invitrogen), transferred onto PVDF membrane (Immobilon-P, Millipore).
Antibody detection was accomplished using enhanced chemiluminescence method (Western
Lightning, PerkinElmer) and LAS-3000 Imaging system (FUJIFILM).
Glutathione assays
Measurement of intracellular reduced (GSH) and oxidized (GSSG) glutathione concentration was
performed using the 5,5’-dithio-bis(2-nitrobenzoic acid)-glutathione reductase recycling method
35

as previously described . Briefly, the rate of 5-thio-2-nitrobenzoic acid (TNB) formation was
determined by measuring the rate of change of absorbance at 412 nm. Linear regressions based
on values obtained from standard curves were used to calculate concentrations of total and
oxidized glutathione, which were then used to calculate concentration of reduced glutathione.
Glutathione concentrations were normalized based on protein concentration determined using the
BCA Kit (Pierce). Reagents for glutathione assays were obtained from Sigma and include 5sulfosalicylic acid dihydrate, DTNB, β-NADPH, glutathione reductase, L-glutathione reduced, Lglutathione oxidized, triethanolamine, and 2-vinylpyridine. P values for statistical analysis were
obtained using Student’s t-test.
Gene expression profiling and heatmap plot
Total RNA was extracted from cells using TRIZOL (Invitrogen) and was subjected to cleanup
using the RNeasy Mini Kit (Qiagen) according to the manufacturers’ instructions. RNA samples
were submitted to the Laboratory for Clinical Genomics at the Washington University in St. Louis
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for gene expression microarray analysis using the GeneChip Mouse Gene 1.0 ST array
(Affymetrix). Heatmap plot was generated using Partek Genomics Suite (Partek).

2.6 Figure Legends
Fig. 2.1. ∆Np63 abrogates DNA damage-induced oxidative stress and enhances clonogenic
-/-

-/-

survival of transformed p53 Bax Bak

-/-

triple-knockout (TKO) mouse embryonic fibroblasts

(MEFs). (A) ∆Np63 but not a dominant negative mutant of p53 prevents DNA damage-induced
-/-

-/-

ROS accumulation. SV40-transformed Bax Bak double-knockout (DKO) MEFs transduced with
control retrovirus or retrovirus expressing ΔNp63α or dominant negative p53 (p53 DN) were mock
treated or treated with etoposide (10 µg/ml). Oxidation of the ROS-sensitive dyes H2DCFDA,
DHE, or MitoSOX Red was quantified by flow cytometric analysis. Data shown are fold increase
of ROS after etoposide treatment. (B) Cell death was quantified by flow cytometric analysis
following propidium iodide staining of DKO cells described in (A) at 3 days after etoposide
treatment. Data are the mean percentage of PI-positive cells ± SD from three independent
experiments. The expression of N-terminal Flag-HA-tagged ∆Np63 and dominant negative p53
was assessed by anti-Flag immunoblot (right panel). Asterisk denotes a cross-reactive band
-/-

serving as a loading control. (C) SV40-transformed Bax Bak

-/-

DKO MEFs transduced with the

indicated retrovirus were treated with etoposide (10 µg/ml) for 14 hours. Colonies were stained
with crystal violet after 12 days. The data shown are representative of three independent
-/-

-/-

experiments. (D) SV40-transformed p53 Bax Bak

-/-

TKO MEFs transduced with control or

ΔNp63α-expressing retrovirus were mock treated or treated with etoposide (10 µg/ml). Oxidation
of the ROS-sensitive dye DHE was quantified by flow cytometric analysis. Data shown are fold
increase of ROS after etoposide treatment. (E) Cell death was quantified by flow cytometric
analysis following propidium iodide staining of TKO cells described in (D) at the indicated times
after etoposide treatment. Data are the mean percentage of PI-positive cells ± SD from three
-/-

-/-

independent experiments. (F) c-Myc/Ras or E1A/Ras transformed p53 Bax Bak

-/-

TKO MEFs

transduced with control retrovirus or retrovirus expressing ΔNp63α were treated with etoposide
for 9 hours. Colonies were stained with crystal violet after 10 days. *, P<0.05.
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Fig. 2.2. p63 dictates the homeostasis of intracellular redox through transcriptional controls of
glutathione metabolism genes. (A) ∆Np63 protects against cell death induced by exogenous
oxidants. Wild-type MEFs transduced with control or ∆Np63-expressing retrovirus were mock
treated or treated with diamide (100 µM) for 4 hours or tert-butyl hydroperoxide (TBH, 50 µM) for
7 hours. Cell death was quantified by propidium iodide (PI) staining. Data are the mean
percentage of PI-positive cells ± SD from three independent experiments. (B) Schematic
representation of the effect of ΔNp63α on glutathione metabolism. Overexpression of ΔNp63α in
cells generates a more reduced intracellular redox state and increases resistance to oxidative
damage through a coordinated regulation of glutathione metabolism genes. Specifically, ΔNp63α
upregulates enzymes responsible for (1) glutathione biosynthesis, (2) ROS detoxification by
glutathione, and (3) regeneration of GSH from GSSG. (C) ∆Np63 upregulates genes involved in
-/-

glutathione metabolism. Bax Bak

-/-

DKO cells transduced with control or ∆Np63-expressing

retrovirus were mock treated or treated with etoposide (10 µg/ml) for 6 hours. mRNA levels of the
indicated genes were analyzed by qRT-PCR and presented as mean ± SD from three
independent experiments. (D) ∆Np63 generates a more reduced intracellular redox state. Bax
Bak

-/-

-/-

DKO MEFs transduced with control or ∆Np63-expressing retrovirus were mock treated or

treated with etoposide for 24 hours. Intracellular reduced (GSH) and oxidized (GSSG) glutathione
concentrations were determined using an enzyme-cycling assay and normalized against protein
concentration. Normalized [GSH] and [GSSG] were used to calculate the GSH/GSSG ratio. Data
presented are mean ± SD from at least three independent experiments. (E to H) The ability of
∆Np63 to prevent DNA damage-induced cell death is compromised by the deficiency of its
-/-

transcriptional targets engaged in glutathione metabolism. Bax Bak

-/-

DKO cells stably

expressing GFP or ΔNp63α were transfected with scrambled siRNA (siScr) or siRNA against
GCLC (E), GSS (F), GPX2 (G), or IDH2 (H). Cells were subsequently mock treated or treated
with etoposide for 3 days. Cell death was quantified by propidium iodide (PI) staining. Data are
the mean percentage of PI-positive cells ± SD from three independent experiments. *, P < 0.05.
Fig. 2.3. Deficiency of ∆Np63α generates a more oxidized intracellular redox state and sensitizes
cells to oxidative stress. (A) The indicated human cell lines transduced with lentivirus expressing
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shRNA against GFP or p63 were analyzed by Western blots using antibodies specific for p63 and
actin. (B) Deficiency of ∆Np63α leads to increased ROS levels. MCF-10A and ME-180 cell lines,
transduced with lentivirus expressing shRNA against GFP or p63, were stained with CMH2DCFDA or H2DCFDA. Oxidation of the respective dyes was quantified by flow cytometric
analysis. Data shown are fold increase of ROS induced by knockdown of p63 from three
independent experiments. (C) Deficiency of ΔNp63α downregulates genes involved in glutathione
metabolism. The indicated human cells lines were transduced with lentivirus expressing shRNA
against GFP or p63. mRNA levels of the indicated genes were analyzed by qRT-PCR and
presented as mean ± SD from three independent experiments. (D) Deficiency of ∆Np63α
generates a more oxidized intracellular redox state. The indicated human cell lines transduced
with lentivirus expressing shRNA against GFP or p63 were analyzed for intracellular reduced
(GSH) and oxidized (GSSG) glutathione concentrations using an enzyme-cycling assay.
Normalized [GSH] and [GSSG] were used to calculate the GSH/GSSG ratio. Data presented are
mean ± SD from three independent experiments. (E) Deficiency of ∆Np63α sensitizes cells to
oxidant-induced cell death. The indicated human cell lines transduced with lentivirus expressing
shRNA against GFP or p63 were mock treated or treated with oxidant diamide in combination
with antioxidant N-acetyl-L-cysteine (NAC). Cell death was quantified by propidium iodide (PI)
staining. Data are the mean percentage of PI-positive cells ± SD from three independent
experiments. *, P < 0.05.
Fig. 2.4. ΔNp63α mitigates anoikis-induced oxidative stress and cooperates with anti-apoptotic
BCL-2 to disrupt the luminal clearance of acini in three-dimensional culture of mammary epithelial
cells. (A) ΔNp63α protects MCF-10A cells from anoikis. MCF-10A cells transduced with retrovirus
expressing GFP, BCL-2, ΔNp63α, or both BCL-2 and ΔNp63α were grown on poly-HEMA-coated
plates in the presence of 1% methylcellulose to induce anoikis. Cell death was quantified at the
indicated times by annexin-V staining. Data are the mean percentage of annexin-V-positive cells
± SD from three independent experiments. *, P < 0.05. (B) ΔNp63α but not BCL-2 prevents
anoikis-induced ROS accumulation. MCF-10A cells transduced with control retrovirus or
retrovirus expressing BCL-2, ΔNp63α, or both BCL-2 and ΔNp63α were grown on poly-HEMA-
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coated plates in the presence of 1% methylcellulose to induce anoikis. Paired samples grown in
either regular or detachment condition were stained with DHE at 1.5 days. Oxidation of DHE was
quantified by flow cytometric analysis. Data shown are fold increase of ROS induced by anoikis
from three independent experiments. *, P < 0.05. (C and D) Coexpression of BCL-2 and ΔNp63α
disrupts the luminal clearance of acini in three-dimensional culture. MCF-10A cells transduced
with retrovirus expressing GFP, BCL-2, ΔNp63α, or both BCL-2 and ΔNp63α were cultured in
reconstituted basement membrane (Matrigel) for 31 days. Acini were fixed and stained for laminin
5 (red) and nuclear stain 4’,6-diamidino-2-phenylindole (DAPI, blue). Luminal cellularity of acini
was scored using confocal microscopy. Clear, 0-25% of the luminal space filled with cell nuclei;
mostly clear, 25-50%; mostly filled, 50-75%; filled, 75-100%. Representative confocal microscopy
images from three independent experiments are shown (C). Scale bar indicates 25 µm. Data
shown in (D) are average of three independent experiments. (E) ΔNp63α prevents intraluminal
ROS accumulation in three-dimensional acini. MCF-10A cells transduced with retrovirus
expressing GFP, BCL-2, p63, or both BCL-2 and p63 were cultured in Matrigel for 6-8 days. Acini
were stained with DHE (red) and Hoechst 33342 (blue). Representative confocal microscopy
images are shown. Arrowheads indicate DHE-high cells. Scale bar indicates 25 µm.
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2.7 Figures
Figure 2.1 ∆Np63 abrogates DNA damage-induced oxidative stress and enhances
-/-

-/-

-/-

clonogenic survival of transformed p53 Bax Bak mouse embryonic fibroblasts.
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Figure 2.2 p63 dictates the homeostasis of intracellular redox through transcriptional
controls of glutathione metabolism genes.
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Figure 2.3 Deficiency of ∆Np63α generates a more oxidized intracellular redox state and
sensitizes cells to oxidative stress.

	
  

79

Fig. 2.4 ΔNp63α mitigates anoikis-induced oxidative stress and cooperates with antiapoptotic BCL-2 to disrupt the luminal clearance of acini in three-dimensional culture of
mammary epithelial cells.
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-/-

-/-

Fig. S2.1. (A) SV40-transformed Bax Bak DKO MEFs were transfected with scrambled siRNA
(siScr) or siRNA against RIP1. Cell lysates were analyzed by Western blots using the antibodies
-/-

specific for RIP1 or actin. (B) SV40-transformed Bax Bak

-/-

DKO MEFs, transfected with

scrambled siRNA (siScr) or siRNA against RIP1 for 3 days, were treated with etoposide (10
µg/ml). Cell death was quantified by propidium iodide staining at 3 days after etoposide
treatment. Data are the mean percentage of PI-positive cells ± SD from three independent
experiments.

Data courtesy of Dr. Ho-Chou Tu

-/-

-/-

-/-

Fig. S2.2. p53 Bax Bak TKO MEFs are more resistant to DNA damage-induced cell death than
-/-

-/-

-/-

-/-

Bax Bak

p53 Bax Bak
Bak

-/-

-/-

DKO MEFs. (A) Primary MEFs isolated from two Bax Bak
-/-

-/-

DKO embryos and two

TKO embryos were transformed by E1a and Ras. E1a/Ras-transformed Bax
-/-

-/-

DKO and p53 Bax Bak

-/-

-/-

TKO MEFs were treated with etoposide (10 µg/ml). Cell death

was quantified by annexin-V staining at the indicated times. Data are the mean percentage of
annexin-V-positive cells ± SD from three independent experiments. (B) SV40-transformed Bax
-/-

-/-

-/-

-/-

-/-

Bak DKO or p53 Bax Bak TKO MEFs were treated with etoposide (10 µg/ml). Cell death was
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quantified by propidium iodide staining at the indicated times. Data are the mean percentage of
PI-positive cells ± SD from three independent experiments. *, P<0.05.

-/-

-/-

Fig. S2.3. p53 Bax Bak

-/-

TKO cells were treated with etoposide or etoposide plus N-acetyl-L-

cysteine (NAC, 20 mM) or etoposide plus diphenyleneiodonium (DPI, 100 nM) for the indicated
times. Cell death was quantified by propidium iodide staining at the indicated times. Data are the
mean percentage of PI-positive cells ± SD from three independent experiments.

-/-

-/-

Fig. S2.4. SV40-transformed p53 Bax Bak

-/-

TKO MEFs transduced with control or ΔNp63α-

expressing retrovirus were mock treated or treated with etoposide (10 µg/ml). Oxidation of the
ROS-sensitive dye CM-H2DCFDA or MitoSOX Red was quantified by flow cytometric analysis.
Data shown are fold increase of ROS after etoposide treatment. *, P<0.05.
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-/-

Fig. S2.5. (A) cDNA prepared from Bax Bak

-/-

DKO MEFs transduced with control or ΔNp63α-

expressing retrovirus was subjected to PCR using primers specific for all isoforms of p63 (Pan),
-/-

TA isoforms of p63 (TA), or ∆N isoforms of p63 (∆N). (B) SV40-transformed Bax Bak

-/-

DKO

MEFs transduced with retrovirus expressing shRNA against luciferase or p63, or transfected with
scrambled siRNA (siScr) or siRNA against p63 were subjected to quantitative RP-PCR analysis
for p63 expression. Data presented as mean ± SD from three independent experiments. (C)
-/-

SV40-transformed Bax Bak

-/-

DKO MEFs, tranfected with scrambled siRNA (siScr) or siRNA

against p63 for 3 days, were mock treated or treated with etoposide (10 µg/ml) for 3 days (left
panel). DKO MEFs transduced with retrovirus expressing shRNA against luciferase or p63 were
mock treated or treated with etoposide (10 µg/ml) for 3 days (right panel). Cell death was
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quantified by propidium iodide staining. Data are the mean percentage of PI-positive cells ± SD
-/-

-/-

from three independent experiments. (D) SV40-transformed p53 Bax Bak

-/-

TKO MEFs,

tranfected with scrambled siRNA (siScr) or siRNA against p63 for 3 days, were mock treated or
treated with etoposide (10 µg/ml) for 5 days (left panel). TKO MEFs transduced with retrovirus
expressing shRNA against luciferase or p63 were mock treated or treated with etoposide (10
µg/ml) for 5 days (right panel). Cell death was quantified by propidium iodide staining. Data are
the mean percentage of PI-positive cells ± SD from three independent experiments.

Fig. S2.6. A heatmap representation of glutathione metabolism genes differentially regulated by
ΔNp63α. DKO cells transduced with retrovirus expressing GFP or GFP-IRES-ΔNp63α were mock
treated or treated with etoposide (10 µg/ml) for 6 hours. The gene expression profiles were
assessed using the Affymetrix GeneChip Mouse Gene 1.0 ST array and analyzed for genes
involved in glutathione metabolism.
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-/-

-/-

Fig. S2.7. Immunoblot or qRT-PCR analysis of siRNA-mediated knockdown. (A) Bax Bak DKO
MEFs transfected with scrambled siRNA (siScr) or siRNA against IDH2 were analyzed by
-/-

immunoblots using antibodies specific for IDH2 or actin. (B to D) Bax Bak

-/-

DKO MEFs

transfected with scrambled siRNA (siScr) or siRNA against GCLC, GSS, or GPX2 were analyzed
by qRT-PCR using the indicated gene-specific primers. Data presented as mean ± SD from three
independent experiments. *, P<0.05.
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Fig. S2.8. (A) ME-180 cells transfected with scrambled siRNA (siScr) or siRNA against p63 for 3
days were subjected to analysis for ROS production or immunoblots using antibodies specific for
p63 or actin. Oxidation of the ROS-sensitive dye H2DCFDA was quantified by flow cytometric
analysis. (B) ME-180 cells were transduced with lentivirus expressing doxycycline-inducible
miR30-based shRNA against p63. Cells were mock-treated or treated with doxycycline (2 µg/ml)
for three days and analyzed for ROS production and immunoblots using antibodies specific for
p63 or actin. Oxidation of the ROS-sensitive dye H2DCFDA was quantified by flow cytometric
analysis. *, P<0.05.
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Fig. S2.9. (A) MCF-10A cells transduced with lentivirus expressing shRNA against GFP or p63
for 48 hours were mock treated or treated with doxorubicin (1 µg/ml) for 27 hours. Cell death was
quantified by propidium iodide (PI) staining. Data are the mean percentage of PI-positive cells ±
SD from three independent experiments. (B) ME-180 cells transduced with lentivirus expressing
shRNA against GFP or p63 for 48 hours were mock treated or treated with cisplatin (10 µM) for
32 hours. Cell death was quantified by propidium iodide (PI) staining. Data are the mean
percentage of PI-positive cells ± SD from three independent experiments. *, P<0.05.
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-/-

Fig. S2.10. Upregulation of GCLC by ΔNp63α is Nrf2-independent. (A and B) Bax Bak

-/-

DKO

MEFs transduced with retrovirus expressing GFP or GFP-IRES-ΔNp63α were transfected with
scrambled siRNA (siScr) or siRNA against Nrf2. mRNA levels of Nrf2 and GCLC were analyzed
by qRT-PCR and presented as mean ± SD from three independent experiments (A). Cell lysates
were analyzed by Western blots using antibodies specific for GCLC or actin (B). (C) Cells
described above were mock treated or treated with etoposide (10 µg/ml) for 3 days. Cell death
was quantified by propidium iodide staining. Data are the mean percentage of PI-positive cells ±
SD from three independent experiments. *, P < 0.05.

	
  

88

2.8 References
1.

Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science, 267:
1456-1462, 1995.

2.

Yuan, J., Lipinski, M., and Degterev, A. Diversity in the mechanisms of neuronal cell
death. Neuron, 40: 401-413, 2003.

3.

Youle, R. J. and Strasser, A. The BCL-2 protein family: opposing activities that mediate
cell death. Nat Rev Mol Cell Biol, 9: 47-59, 2008.

4.

Lindsten, T., Ross, A. J., King, A., Zong, W.-X., Rathmell, J. C., Shiels, H. A., Ulrich, E.,
Waymire, K. G., Mahar, P., Frauwirth, K., Chen, Y., Wei, M., Eng, V. M., Adelman, D. M.,
Simon, M. C., Ma, A., Golden, J. A., Evan, G., Korsmeyer, S. J., MacGregor, G. R., and
Thompson, C. B. The combined functions of proapoptotic Bcl-2 family members Bak and
Bax are essential for normal development of multiple tissues. Mol. Cell, 6: 1389-1399,
2000.

5.

Wei, M. C., Zong, W. X., Cheng, E. H., Lindsten, T., Panoutsakopoulou, V., Ross, A. J.,
Roth, K. A., MacGregor, G. R., Thompson, C. B., and Korsmeyer, S. J. Proapoptotic BAX
and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 292: 727730, 2001.

6.

Cheng, E. H., Wei, M. C., Weiler, S., Flavell, R. A., Mak, T. W., Lindsten, T., and
Korsmeyer, S. J. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing
BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell, 8: 705-711, 2001.

7.

Ren, D., Tu, H. C., Kim, H., Wang, G. X., Bean, G. R., Takeuchi, O., Jeffers, J. R.,
Zambetti, G. P., Hsieh, J. J., and Cheng, E. H. BID, BIM, and PUMA are essential for
activation of the BAX- and BAK-dependent cell death program. Science, 330: 1390-1393,
2010.

8.

Kim, H., Rafiuddin-Shah, M., Tu, H. C., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J., and
Cheng, E. H. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2
subfamilies. Nat Cell Biol, 8: 1348-1358, 2006.

	
  

89

9.

Kim, H., Tu, H. C., Ren, D., Takeuchi, O., Jeffers, J. R., Zambetti, G. P., Hsieh, J. J., and
Cheng, E. H. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates
mitochondrial apoptosis. Mol Cell, 36: 487-499, 2009.

10.

Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev, 15: 2922-2933.,
2001.

11.

Tu, H. C., Ren, D., Wang, G. X., Chen, D. Y., Westergard, T. D., Kim, H., Sasagawa, S.,
Hsieh, J. J., and Cheng, E. H. The p53-cathepsin axis cooperates with ROS to activate
programmed necrotic death upon DNA damage. Proc Natl Acad Sci U S A, 106: 10931098, 2009.

12.

Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., and Kroemer, G. Molecular
mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol, 11:
700-714, 2010.

13.

Zong, W. X., Ditsworth, D., Bauer, D. E., Wang, Z. Q., and Thompson, C. B. Alkylating
DNA damage stimulates a regulated form of necrotic cell death. Genes Dev, 18: 12721282, 2004.

14.

Debnath, J., Mills, K. R., Collins, N. L., Reginato, M. J., Muthuswamy, S. K., and Brugge,
J. S. The role of apoptosis in creating and maintaining luminal space within normal and
oncogene-expressing mammary acini. Cell, 111: 29-40, 2002.

15.

Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S.,
Puigserver, P., and Brugge, J. S. Antioxidant and oncogene rescue of metabolic defects
caused by loss of matrix attachment. Nature, 461: 109-113, 2009.

16.

Festjens, N., Vanden Berghe, T., and Vandenabeele, P. Necrosis, a well-orchestrated
form of cell demise: signalling cascades, important mediators and concomitant immune
response. Biochim Biophys Acta, 1757: 1371-1387, 2006.

17.

Dotsch, V., Bernassola, F., Coutandin, D., Candi, E., and Melino, G. p63 and p73, the
ancestors of p53. Cold Spring Harb Perspect Biol, 2: a004887, 2010.

18.

Balaban, R. S., Nemoto, S., and Finkel, T. Mitochondria, oxidants, and aging. Cell, 120:
483-495, 2005.

	
  

90

19.

Flores, E. R., Tsai, K. Y., Crowley, D., Sengupta, S., Yang, A., McKeon, F., and Jacks, T.
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.
Nature, 416: 560-564, 2002.

20.

Suh, E. K., Yang, A., Kettenbach, A., Bamberger, C., Michaelis, A. H., Zhu, Z., Elvin, J.
A., Bronson, R. T., Crum, C. P., and McKeon, F. p63 protects the female germ line during
meiotic arrest. Nature, 444: 624-628, 2006.

21.

Trachootham, D., Alexandre, J., and Huang, P. Targeting cancer cells by ROS-mediated
mechanisms: a radical therapeutic approach? Nat Rev Drug Discov, 8: 579-591, 2009.

22.

Meister, A. Glutathione metabolism and its selective modification. J Biol Chem, 263:
17205-17208, 1988.

23.

Godar, S., Ince, T. A., Bell, G. W., Feldser, D., Donaher, J. L., Bergh, J., Liu, A., Miu, K.,
Watnick, R. S., Reinhardt, F., McAllister, S. S., Jacks, T., and Weinberg, R. A. Growthinhibitory and tumor- suppressive functions of p53 depend on its repression of CD44
expression. Cell, 134: 62-73, 2008.

24.

Yan, W. and Chen, X. GPX2, a direct target of p63, inhibits oxidative stress-induced
apoptosis in a p53-dependent manner. J Biol Chem, 281: 7856-7862, 2006.

25.

Motohashi, H. and Yamamoto, M. Nrf2-Keap1 defines a physiologically important stress
response mechanism. Trends Mol Med, 10: 549-557, 2004.

26.

Hayes, J. D. and McMahon, M. NRF2 and KEAP1 mutations: permanent activation of an
adaptive response in cancer. Trends Biochem Sci, 34: 176-188, 2009.

27.

Senoo, M., Pinto, F., Crum, C. P., and McKeon, F. p63 Is essential for the proliferative
potential of stem cells in stratified epithelia. Cell, 129: 523-536, 2007.

28.

Keyes, W. M., Wu, Y., Vogel, H., Guo, X., Lowe, S. W., and Mills, A. A. p63 deficiency
activates a program of cellular senescence and leads to accelerated aging. Genes Dev,
19: 1986-1999, 2005.

29.

Keyes, W. M., Pecoraro, M., Aranda, V., Vernersson-Lindahl, E., Li, W., Vogel, H., Guo,
X., Garcia, E. L., Michurina, T. V., Enikolopov, G., Muthuswamy, S. K., and Mills, A. A.

	
  

91

DeltaNp63alpha is an oncogene that targets chromatin remodeler Lsh to drive skin stem
cell proliferation and tumorigenesis. Cell Stem Cell, 8: 164-176, 2011.
30.

DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K.,
Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., Scrimieri, F., Winter, J. M., Hruban, R.
H., Iacobuzio-Donahue, C., Kern, S. E., Blair, I. A., and Tuveson, D. A. Oncogeneinduced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature, 475:
106-109, 2011.

31.

Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L.,
and Sabatini, D. M. The Rag GTPases bind raptor and mediate amino acid signaling to
mTORC1. Science, 320: 1496-1501, 2008.

32.

Takeda, S., Chen, D. Y., Westergard, T. D., Fisher, J. K., Rubens, J. A., Sasagawa, S.,
Kan, J. T., Korsmeyer, S. J., Cheng, E. H., and Hsieh, J. J. Proteolysis of MLL family
proteins is essential for taspase1-orchestrated cell cycle progression. Genes Dev, 20:
2397-2409, 2006.

33.

Debnath, J., Muthuswamy, S. K., and Brugge, J. S. Morphogenesis and oncogenesis of
MCF-10A mammary epithelial acini grown in three-dimensional basement membrane
cultures. Methods, 30: 256-268, 2003.

34.

Nelson, C. M., Inman, J. L., and Bissell, M. J. Three-dimensional lithographically defined
organotypic tissue arrays for quantitative analysis of morphogenesis and neoplastic
progression. Nat Protoc, 3: 674-678, 2008.

35.

Rahman, I., Kode, A., and Biswas, S. K. Assay for quantitative determination of
glutathione and glutathione disulfide levels using enzymatic recycling method. Nat
Protoc, 1: 3159-3165, 2006.

	
  

92

-CHAPTER THREE-

DNA Damage Induces Mitochondrial ROS Production to
Execute Programmed Necrotic Death
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3.1 Introduction
Reactive oxygn species (ROS) are potentially harmful reactive derivatives of molecular
1

oxygen that can damage all intracellular constituents . Although they are proposed to be central
2

initiators and effectors of programmed necrosis under diverse settings , much about their
regulation in this setting remain unknown. Mitochondria are the primary sources of ROS in most
cell types and are proposed to be major sources of ROS production during programmed
2

necrosis . ROS production occurs during normal physiological processes such as fatty acid
3

catabolism and aerobic respiration, and are countered by cellular antioxidant defences .
Excessive production and/or impaired antioxidant capacity generates a deleterious state of
1

oxidative stress, which can lead to cellular dysfunction and demise . Intracellular ROS is primarily
produced by the mitochondrial electron transport chain (ETC) as the unavoidable byproduct of
3

aerobic respiration . The leakage of electrons passing through the ETC leads to the one-electron
reduction of O2 to O2

•—

(superoxide), which can then give rise to other ROS such as the hydroxyl

3

radical .
Depending on the nature of the initial death signal, broadly similar models have emerged
to explain the mechanism underlying increased mitochondrial ROS production during
programmed necrosis, with the commonality being that increased electron flow into the ETC is
2

proposed to cause increased rate of electron leakage, and hence excessive ROS production .
With death receptor ligation-induced RIP1 kinase-dependent “necroptosis”, this can be caused by
increased entry of energy substrates into the tricarboxylic acid (TCA) cycle due to upregulation of
glycolysis and glutamine metabolism, itself due to phosphorylation-mediated stimulation of
4

metabolic enzymes by the RIP1 interacting partner RIP3 kinase . TNF receptor ligation can also
5

induce superoxide production by the NAPDH oxidase Nox1 to execute necrosis . In the case of
ischemia-reperfusion injury, ATP depletion during ischemia impairs the ability of ATP-dependent
calcium pumps to extrude calcium from the cytosol into the endoplasmic reticulum (ER) or the
6

2+

2+

extracellular space . Increased cytosolic [Ca ] leads to elevated mitochondrial matrix [Ca ],
6

which stimulates TCA cycle enzymes and thus electron entry into the ETC . This acute increase
6

in mitochondrial oxidative metabolism leads to a burst of ROS generation following reperfusion .
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We have reported that DNA double strand break (DSB)-induced programmed necrotic
death (PND) requires de novo gene expression and is executed by the p53-mediated induction of
the lysosomal protease cathepsin Q in cooperation with p53-independent induction of reactive
7

-/-

oxygen species (ROS) . DNA DSB-induced PND in Bax Bak

-/-

double knockout (DKO) mouse

7

embryonic fibroblasts (MEFs) does not rely on RIP1 , thus making it unlikley for RIP3-mediated
metabolic upregulation to be responsible for ROS production since RIP3 is phosphorylated and
activated by RIP1 in the necrosome. Genotoxic stress induced by DNA alkylation has previously
8

been shown to deplete cellular ATP due to overactivation of the DNA repair enzyme PARP1 .
7

However, we found that PND induced by DSBs is not dependent on PARP1 . Furthermore, in our
7

setting, DNA damage-induced ROS production and death requires de novo gene expression , an
ATP-dependent process. Additionally, this form of programmed necrosis is also independent of
cyclophilin D, a primary mediator of calcium-induced necrosis

9-11

. Thus, it is unlikely for increased

ROS production to be secondary to ATP depletion and calcium dysregulation, as in the case of
ischemia-reperfusion injury. Although it is clear that there is a regulated production of ROS in this
setting, the underlying mechanism(s) are unknown and will be the focus of this chapter.

3.2 Results
Though it is unlikely for ATP depletion and subsequent calcium dysregulation to be
responsible for double strand break-induced ROS production, we nevertheless sought to rule out
this possible by comparing the kinetics of mitochondrial ROS production and cell death with
changes in cellular ATP levels. Following treatment of transformed Bax and Bak DKO MEFs with
the topoisomerase II inhibitor etoposide, which generates DNA double strand breaks, an early
and sustained rise in mitochondrial matrix superoxide levels was detected by the matrix-localized
superoxide-specific indicator dye MitoSOX Red (Fig. 3.1A) prior to any detectable cell death (Fig.
3.1B). Surprisingly, there was a burst of ATP production at 12 hours following etoposide
treatment, coinciding with the time frame during which superoxide started to increase (Fig. 3.1C).
Subsequently, ATP levels continued to decline following ROS induction (Fig. 3.1C). These data
indicate that mitochondrial ROS production is not caused by bioenergetic collapse, as in the case
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of ischemia-reperfusion injury. Rather, the early increase in ATP levels suggest that double
strand breaks may induce an early upregulation of ETC activity, leading to ATP and superoxide
generation. The latter then cooperates with cathepsin Q, with deleterious and eventually lethal
consequences for the cell.
The ETC is located in the mitochondrial inner membrane and generates the
12

electrochemical gradient required for ATP generation . Electrons enter the ETC via complex I or
II and are carried from both by ubiquinone to complex III, then transferred via cytochrome c to
complex IV, where they leave via the reduction of molecular oxygen to water

12

(Fig. 3.2A). Of

these, complex I and III are accepted as the major sources of electron leakage and hence
mitochondrial superoxide production, with a minor contribution by complex II implicated in specific
3

settings . To determine whether or not the ETC plays a role in DNA damage-induced ROS
production, we assayed for the intrinsic enzymatic activity of the ETC complexes I, II, III, and IV in
isolated mitochondria. Indeed, treatment with etoposide increased the enzymatic activity of
complexes III and IV, but not of the others. Notably, etoposide did not affect the activity of the
mitochondrial matrix enzyme citrate synthase (Fig. 3.2, B to F). Since complex IV is not a site of
superoxide formation, this suggests DNA damage increases mitochondrial ROS production via
induction of ETC complex III.
12

Complex III of the ETC is composed of 11 subunits . The mechanism of superoxide
13

production at complex III is as follows : 1) complexes I and II transfer two electrons to the mobile
electron carrier ubiquinone, forming the reduced ubiquinol; 2) the Rieske iron-sulfur protein
(RISP) subunit of complex III, encoded by the gene Uqcrfs1, sequentially transfers one electron
at a time from ubiquinol to cytochrome c; 3) sequential single electron oxidation of ubiquinol
transiently creates the free radical ubisemiquinone, which can then either donate its remaining
electron to other complex III electron carriers, or donate directly to oxygen to generate
superoxide. RNAi-mediated knockdown of the RISP subunit prevents ubisemiquinone formation,
thus abolishing complex III ROS production

13-15

. Therefore, to test the role of complex III in DNA

damage-induced ROS and cell death, we used RNAi to knockdown the RISP. We found that
knockdown of RISP was able to prevent both ROS induction (Fig. 3.2G) and cell death (Fig. 3.2H)
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following treatment with etoposide. In contrast, knockdown of the essential ETC complex I
chaperon protein Ndufaf1, loss of which decreases complex I abundance and activity

16

and

17

inhibits antigen receptor-induced ROS production in T lymphocytes , did not protect against
etoposide-induced ROS (Fig. 3.2H) and cell death (Fig. 3.2H), in line with our observation that
etoposide did not alter complex I activity.
We next sought to determine whether the canonical ATM-mediated DNA damage
response to double strand breaks is involved in the induction of ETC complex III activity and ROS
by etoposide. ATM is a phosphatidylinositol 3-kinase (PI3K)-related kinase (PIKK) whose activity
can be inhibited using the compound LY294002. This compound also inhibits PI3Ks as well as
ATR and DNA-PK, two other PIKKs involved in the DNA damage checkpoint. Though both ATR
and DNA-PK have been implicated in the response to double strand breaks, ATM is widely
considered to be the primary mediator

18-20

. Importantly, we demonstrated that LY294002 blocked

etoposide-induced ROS as measured by the broad-spectrum ROS indicator H2DCFDA, the nonmitochondria-specific superoxide indicator dihydroethidium (DHE), and MitoSOX Red (Fig. 3.3A);
and protected against cell death (Fig. 3.3B). Furthermore, RNAi-mediated knockdown of ATM
using two siRNA oligos targeting distinct regions of ATM mRNA provided modest but significant
inhibition of etoposide-induced ROS using all three ROS indicator dyes (Fig. 3.3C), and also
protected against death (Fig. 3.3D). Knockdown of ATM was confirmed by qRT-PCR (Fig. 3.3E).
The difference in protection afforded by knockdown of ATM versus treatment with LY294002
suggests that ATR and DNA-PK are also involved. Notably, ATM provided much greater
protection against cell death (Fig. 3.3D) than against ROS induction (Fig. 3.3C). This is most
likely due to abrogation of ATM-mediated activation of p53, whose transcriptional target cathepsin
Q cooperates in parallel with ROS to execute programmed necrotic death.
These results provided clear indication that the canonical double strand break-induced
DNA damage signaling pathway may be involved in upregulating ETC complex III activity in
response to etoposide. Indeed, LY294002 was able to completely prevent the induction of ETC
complex III activity triggered by treatment with etoposide (Fig. 3.3F). Immunoblot analysis of the
mitochondrial outer membrane protein VDAC1 showed it was present in equal amounts between
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all samples of isolated mitochondria used for the complex III activity assay (Fig. 3.3G), indicating
differences in its activity was not due to differences in purity of the mitochondria preparations.

3.3 Materials and Methods
siRNA
siRNA oligos were reverse-transfected using LipofectamineTM RNAiMAX (Invitrogen) to a final
concentration of 10. The mouse siRNA oligos were purchased from Ambion Silencer Select
oligos (Applied Biosystems): Ndufaf1 #1, 5’-GACACGGAGUUUAUCCAGAtt (Ambion s88121);
Ndufaf1

#2,

5’-GGCAGUUUCGUGAAAAAGAtt

CGACUUCUCUGACUAUCGUtt

(Ambion

(Ambion
s83717);

s206245);
Uqcrfs1

Uqcrfs1
#2,

#1,

5’5’-

GCAUGAUUUAGAUCGAGUAtt (Ambion s83718); ATM #1, 5’-CAUCUAAUGGUCUAACGUAtt
(Ambion s62693); ATM #2, 5’-GGCUUUUUCCUACGAUUAUtt (Ambion s62694; Ambion Silencer
Select Negative Control #1.

Reverse transcription and quantitative PCR
Total RNA was extracted from cells using TRIZOL (Invitrogen) according to the manufacturer’s
instruction. Reverse transcription was performed with oligo-dT plus random decamer primers
(Ambion) using Superscript II (Invitrogen). Quantitative PCR was performed with SYBR green
master mix (Applied Biosystems) in duplicates using indicated gene specific primers. For TaqMan
probes, quantitative PCR was performed with TaqMan PCR Master Mix (Applied Biosystems).
Quantitative PCR was performed on an ABI Prism 7300 sequence detection system (Applied
Biosystems). Data were analyzed as described previously by normalization against GAPDH that
7

was detected using TaqMan probes (Applied Biosystems) .

Cell culture and viability assays
-/-

-/-

SV40-transformed Bax Bak double-knockout (DKO) mouse embryonic fibroblasts (MEFs) were
7

previously described . Cell death was quantified by propidium iodide (Sigma) staining, followed
by flow cytometric analysis using either a FACSCalibur (BD Biosciences) or a LSRFortessa (BD
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Biosciences). Data were analyzed using CellQuest Pro (BD Biosciences) or FACSDiva (BD
Biosciences). P values for statistical analyses were obtained using Student's t test.

Measurement of ROS
Production of ROS was monitored by flow cytometric analyses using ROS-sensitive dyes. Cells
were incubated with 1 µM 2’,7’-dichlorofluorescein diacetate (H2DCFDA, Invitrogen) or 1 µM
dihydroethidium (DHE, Invitrogen) at 37°C for 30 minutes, or with 2.5 µM MitoSOX Red
(Invitrogen) at 37°C for 10 minutes. Oxidation of the ROS-sensitive dye was quantified by flow
cytometric analysis using either a FACSCalibur (BD Biosciences) or a LSRFortessa (BD
Biosciences). Median fluorescence in the appropriate detection channels was assessed by
FlowJo (Tree Star). Fold induction of ROS was determined by dividing the median fluorescence
of experimental samples with that of control samples. P values for statistical analyses were
obtained using Student’s t-test.

Reagents
Chemicals used are listed as follows: etoposide, acetyl-CoA, malonate, cytochrome C, DCPIP,
sodium succinate, DTNB, oxaloacetic acid, rotenone, decylubiquinone, antimycin A, sodium
borohydride, propidium iodide, LY294002 (all Sigma); NADH (Roche).

Mitochondrial isolation, antibodies, and immunoblot analysis
Isolation of mitochondria was performed using trituration and differential centrifugation as
previously described

21

, using SHE buffer (250 mM D-sucrose, 10 mM HEPES pH 7.4, 1 mM

EGTA, 0.5 mM PMSF). For electron transport chain activity assays, disruption of mitochondrial
membranes was achieved with 3 freeze-thaw cycles followed by sonication; mitochondria were
aliquoted and stored at -80C until use in assays. For immunoblot analysis, lysate was prepared
from an aliquot of intact mitochondria taken prior to free-thaw and sonication and was resolved by
10% NuPAGE gel (Invitrogen) and transferred onto PVDF membrane (Immobilon-P, Millipore).
Antibody detection was accomplished using enhanced chemiluminescence method (Western
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Lightning, PerkinElmer) and LAS-3000 Imaging system (FUJIFILM). Anti-VDAC1 antibody
(Mouse anti-Porin 31HL, Calbiochem) was used for immunblot analysis.

Electron transport chain activity assays
Spectrophotometric assays for electron transport chain complex I-IV and citrate synthase
activities using isolated mitochondria have been previously described

22

and are summarized

below. Complex I: NADH:ubiquinone oxidoreductase activity was determined by incubating
mitochondria in 25 mM K-phosphate buffer pH 7.5 containing 2.5 mg/mL BSA, 5 mM MgCl2, 0.1
mM NADH, 0.6 mM KCN, and 130 mM decylubiquinone, and either with or without 10 mM
rotenone in order to determine Complex I-specific, rotenone-sensitive activity. Oxidoreductase
activity was calculated from the rate of decrease in absorbance at 340 nm due to NADH
-1

-1

oxidation. Molar extinction coefficient for NADH = 6290 M cm . Complex II: Succinate
dehydrogenase activity was determined by incubating mitochondria in 30 mM K-phosphate buffer
pH 7.5 containing 20 mM sodium succinate, 3 mM KCN, 50 mM DCPIP, and 130 mM
decylubiquinone, and either with or without 5 mM malonate in order to determine Complex IIspecific, malonate-sensitive activity. Dehydrogenase activity was calculated from the rate of
decrease in absorbance at 600 nm due to DCPIP oxidation. Molar extinction coefficient for DCPIP
-1

-1

= 19100 M cm . Complex III: Ubiquinol:cytochrome c oxidoreductase activity was determined
by incubating mitochondria in buffer containing 26.7 mM KH2PO4, 2.58 mM EDTA, 0.516 mM
KCN, 8.6% DMSO, 92.8 mM decylubiquinol, 0.1% oxidized cytochrome c, pH 7.5, either with or
without 50 nM antimycin A to determine Complex III-specific, antimycin A-sensitive activity.
Oxidoreductase activity was calculated from the rate of increase in absorbance at 550 nm due to
-1

-1

cytochrome c reduction. Molar extinction coefficient for cytochrome c = 18500 M cm . Complex
IV: Cytochrome c oxidase activity was determined by incubating mitochondria in 10 mM Kphosphate buffer pH 7 containing 0.1% reduced cytochrome c, with non-specific activity
determined by performing the reaction without mitochondria. Oxidase activity was calculated from
the rate of decrease in absorbance at 550 mm due to cytochrome c oxidation. Molar extinction
-1

-1

coefficient for cytochrome c = 18500 M cm . Citrate synthase: Activity was determined by
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incubating mitochondria in 40.4 mM Tris-Cl buffer pH 8.1 containing 0.06 mM Acetyl-CoA, 0.1
mM DTNB, 0.048% Triton-X 100, and 0.5 mM oxaloacetic acid. Citrate synthase activity was
calculated from the rate of increase in absorbance at 412 nm due to formation of 5-thio-2nitrobenzoate anion from DTNB, with non-specific formation determined by performing the
reaction without oxaloacetic acid. Molar extinction coefficient for 5-thio-2-nitrobenzoate anion =
-1

-1

13600 M cm . Enzyme activity for all assays were calculated as follows: Activity (nmol / min
/ mg protein) = ΔAbs/(Molar extinction coefficient x protein concentration x volume sample).
Mitochondria protein concentration was determined using BCA Kit (Pierce).

ATP assay
Cellular

ATP

levels

were

measured

by

the

luciferin/luciferase

method

using

ATP

Bioluminescence Assay Kit HS II (Roche) per manufacturer’s instructions. Lysates used for ATP
4

determination were prepared from 10 cells for each condition, as determined by staining with
Trypan blue and counting on a hemocytometer. Upon automatic injection of 50 µl of luciferase
reagents to 50 µl of diluted samples, the luminescence signal was integrated for 10 sec after a
delay of 1 sec using a Dynex MLX96-well Plate Luminometer (MTX Lab Systems, Inc). Control
samples were harvested from subconfluent cell populations.

3.4 Discussion
We previously reported that DNA double strand breaks activate programmed necrotic
death via induction of the lysosomal protease cathepsin Q and ROS in a manner dependent on
7

de novo gene expression . Although that study revealed p53 as the transcription factor
responsible for cathepsin Q upregulation, the mechanism underlying ROS induction was unclear.
Here, we conclude that the DNA damage signalling pathway mediated by ATM/ATR/DNA-PK is
responsible for etoposide-induced ROS via increasing the activity of the ETC complex III. The
mechanism of ETC complex III activity induction will be the focus of future investigation.
Given the rapid rise in matrix superoxide (almost two-fold 18 hours following etoposide
treatment) following etoposide treatment and the dependence of ROS induction on de novo gene
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expression, the most likely mechanism for ROS induction is the transcriptional upregulation of a
regulatory protein that alters the activity of existing complex III subunits via protein modification.
This is more likely than direct transcriptional upregulation of complex III subunits due to the
kinetics of mitochondrial superoxide induction and the complexity of this enzyme complex. ETC
complex III consists of 10 subunits encoded by nuclear DNA and 1 subunit encoded by
12

mitochondrial DNA . The mature complex functions as a homodimer and is assembled and
12

embedded into the mitochondrial inner membrane in a multi-step process . Assembly involves
the formation of three subcomplexes that assemble into a membrane-embedded precomplex,
which homodimerize with another precomplex before full assembly is completed with the addition
12

of the final subunits .
Two likely candidates that may mediate ATM/ATR/DNA-PK-induced upregulation of
complex III activity are p73 and PGC-1α. p73 is a member of the p53/p63/p73 family of
transcription factors and is known to mediate cell cycle arrest and apoptosis in response to
23

genotoxic stress . Furthermore, loss of function studies revealed that deficiency of p73 protects
24

against DNA damage-induced cell death . Genotoxic stress can activate p73 via the ATM and
25

26

ATR effector kinases Chk2 and Chk1 ; and also via the p38 MAP kinase (MAPK) pathway ,
18

which can be activated in an ATM/ATR-dependent manner in response to genotoxic stress . p38
27

MAPK can also activate the transcriptional co-activator PGC-1α , a master regulator of oxidative
28

metabolism with an important role in regulating mitochondrial gene expression and biogenesis .
Phosphorylation of PGC-1α by the p38 MAPK leads to its stabilization and activation, resulting in
27

increased mitochondrial respiration . PGC-1α can also be activated via phosphorylation by
29

AMPK . Intriguingly, etoposide was recently shown to activate PGC-1α and mitochondrial
30

biogenesis via AMPK in an ATM-dependent manner . Therefore, double strand breaks may
induce increased ETC complex III activity via activation of PGC-1α.
The identity of the downstream transcriptional targets that are ultimately responsible for
regulating ETC complex III activity in response to double strand breaks is unclear due to a lack of
characterization of complex III post-translational regulation. However, existing data on the bettercharacterized ETC complexes I and IV provides some insight into possible regulatory
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mechanisms. Both complex I and IV have been demonstrated to be regulated via
31

phosphorylation . Phosphorylation of human complex I NDUFS4 subunit at serine 173 promotes
its mitochondrial matrix import and maturation

32

while phosphorylation of bovine complex IV
33

catalytic subunit I at tyrosine 304 leads to its inactivation . Other phosphorylation sites have also
been identified for complex I and complex IV, though the functional consequences of those are
unclear. Furthermore, complex I is positively regulated through deacetylation
nitrosylation of its 75 kDa subunit

35, 36

34

and inhibited by S-

. Although proteomics studies suggest complex III also
31

undergoes phosphorylation, the residues, effects, and mediators of this are unclear . However,
the emerging prominence of post-translational as a mechanism for regulating complex I and IV
activity suggests complex III is likely to be regulated in a similar manner. Especially provocative is
our finding that complex IV activity is also upregulated following DNA double strand breaks to a
similar extent as complex III (Fig. 3.2E), suggesting possible post-translational co-regulation of
these complexes.
Impaired apoptosis is frequently observed in cancers, with evasion of cell death being a
37

hallmark of cancer progression . Recently, cancerous cells have also been proposed to exhibit
an increased need for antioxidant defences compared to noncancerous cells, likey due to
38

metabolic derangements and microenvironmental factors that increase ROS production .
Therefore, pharmacological induction of oxidative is currently being evaluated for use as
38

chemotherapy . Our study demonstrates a novel mechanism by which DNA double strand
breaks can induce increased mitochondrial ROS production in apoptosis incompetent cells. This
suggests that chemotherapeutic strategies combining genotoxic agents with therapeutics that
increase mitochondrial oxidative stress may prove particularly beneficial in the clinical setting.

3.5 Figure Legends
Figure 3.1 Induction of mitochondrial matrix ROS by DNA damage is an early event that
precedes cell death and ATP depletion
(A)

DNA damage induces early increase of mitochondrial matrix ROS in Bax and Bak DKO
MEFs. SV40-transformed DKO MEFs were mock treated or treated with etoposide (10
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µg/ml). At the indicated time points following treatment, oxidation of the mitochondrial
matrix-targeted ROS-sensitive dye MitoSOX Red was quantified by flow cytometric
analysis. Data shown are fold increase of ROS after etoposide treatment. Data presented
are mean ± SD from three independent experiments.
(B)

DNA damage-induced death of DKO MEFs is observed following rise in mitochondrial
matrix ROS. DKO MEFs were mock treated or treated with etoposide (10 µg/ml) as in (A).
At the indicated time points following treatment, cell viability was assessed by propidium
iodide (PI) staining followed by flow cytometric analysis. Data presented are mean
percentage of PI positive cells ± SD from three independent experiments.

(C)

DNA damage-induced ATP depletion in DKO MEFs occurs later than ROS induction.
DKO MEFs were mock-treated or treated with etoposide (10 µg/ml) as in (A). At indicated
time points following treatment, equal numbers of cells were taken from mock-treated or
etoposide-treated samples for the determination of [ATP]. Data presented are mean ± SD
from three independent experiments.

Figure 3.2 ETC complex III mediates DNA double strand break-induced ROS and necrosis
(A)

Flow of electrons through the mitochondrial electron transport chain. Electrons enter the
chain via complex I or compex II; they are transferred to ubiquinol (Q) which carries them
to complex III; cytochrome c carries electrons from complex III to complex IV, where they
reduce molecular oxygen to water.

(B)

DKO MEFs were mock-treated or treated with etoposide (10 µg/ml). 40 hours after
etoposide treatment, mitochondria were isolated and used to determine the activity of
electron transport chain complex I. Data presented are mean ± SD from three
independent experiments.

(C)

Mitochondria isolated from MEFs following 40 hours of mock or etoposide (10 µg/ml)
treatment, as in (B), were used to determine activity of electron transport chain complex
II. Data presented are mean ± SD from three independent experiments.
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(D)

Mitochondria isolated from MEFs following 40 hours of mock or etoposide (10 µg/ml)
treatment, as in (B), were used to determine activity of electron transport chain complex
III. Data presented are mean ± SD from three independent experiments. *, P < 0.05.

(E)

Mitochondria isolated from MEFs following 40 hours of mock or etoposide (10 µg/ml)
treatment, as in (B), were used to determine activity of electron transport chain complex
IV. Data presented are mean ± SD from three independent experiments. *, P < 0.05.

(F)

Mitochondria isolated from MEFs following 40 hours of mock or etoposide (10 µg/ml)
treatment, as in (B), were used to determine activity of citrate synthase. Data presented
are mean ± SD from three independent experiments.

(G)

Deficiency of complex III but not complex I activity protects DKO MEFs against DNA
damage-induced ROS. DKO MEFs were transfected with scrambled siRNA (siScr), or
siRNA against the Ndufaf1 subunit of electron transport chain complex I or against the
RISP subunit of complex III (encoded by the gene Uqcrfs1). Cells were subsequently
mock-treated or treated with etoposide (10 µg/ml) for two days before oxidation of the
ROS-sensitive dye H2DCFDA was quantified by flow cytometric analysis. Data shown are
fold increase of ROS after etoposide treatment. Data presented are mean ± SD from
three independent experiments.

(H)

Deficiency of complex III but not complex I activity protects DKO MEFs against DNA
damage-induced death. DKO MEFs were transfected with scrambled siRNA (siScr), or
siRNA against the Ndufaf1 subunit of electron transport chain complex I or against the
RISP subunit of complex III (encoded by the gene Uqcrfs1). Cells were subsequently
mock-treated or treated with etoposide (10 µg/ml) for three days before cell viability was
assessed by staining with PI followed by flow cytometric analysis. Data are presented as
mean percentage of PI-positive cells ± SD from three independent experiments.

Figure 3.3 DNA damage response pathway induces ROS, necrotic death, and ETC complex
III activity
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(A)

Inhibition of ATM/ATR/DNA-PK-mediated DNA damage signaling protects against DNA
damage-induced ROS. DKO MEFs were treated with LY294002 (50 mM), etoposide (10
mg/mL), or both. Conditions using LY294002 were pre-treated with the drug for 30
minutes before mock or etoposide treatment. Two days after drug treatment, oxidation of
the redox-sensitive dyes H2DCFDA, dihydroethidium (DHE), and MitoSOX Red were
quantified by flow cytometric analysis. Data shown are fold increase of ROS after
etoposide treatment. Data presented are mean ± SD from three independent
experiments.

(B)

Inhibition of ATM/ATR/DNA-PK-mediated DNA damage signaling protects against DNA
damage-induced death. DKO MEFs were treated as in (A). Three days after drug
treatment, cell viability was assessed using PI staining followed by flow cytometric
analysis. Data presented are mean percentage of PI positive cells ± SD from three
independent experiments.

(C)

Loss of ATM protects DKO MEFs against DNA damage-induced ROS. DKO MEFs were
transfected with scrambled siRNA (siScr) or siRNA against ATM. Cells were
subsequently mock-treated or treated with etoposide (10 µg/ml) for two days before
oxidation of the ROS-sensitive dyes H2DCFDA, DHE, and MitoSOX Red were quantified
by flow cytometric analysis. Data shown are fold increase of ROS after etoposide
treatment. Data presented are mean ± SD from three independent experiments. *, P <
0.05.

(D)

Loss of ATM protects DKO MEFs against DNA damage-induced death. DKO MEFs were
transfected as in (C) and mock-treated or treated with etoposide (10 µg/ml). Three days
following etoposide treatment, cell viability was assessed using PI staining followed by
flow cytometric analysis. Data presented are mean percentage of PI positive cells ± SD
from three independent experiments

(E)

DKO MEFs transfected as in (C) were analyzed for ATM expression by qRT-PCR.

(F)

Inhibition of ATM/ATR/DNA-PK-mediated DNA damage signaling protects DKO MEFs
against DNA damage-induced upregulation of ETC complex III activity. DKO MEFs were
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treated with LY294002 (50 mM), etoposide (10 mg/mL), or both, as in (A). 24 hours after
etoposide treatment, mitochondria were isolated and used to determine the activity of the
electron transport chain complex III. Data presented are mean ± SD from three
independent experiments. *, P < 0.05.
(G)

Protein lysates prepared from mitochondrial samples described in (F) were assessed for
VDAC1 expression by anti-VDAC1 immunoblot. LY = LY294002. Etop = etoposide.
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3.6 Figures
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Figure 3.3 DNA damage response pathway induces ROS, necrotic death, and ETC complex
III activity
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-CHAPTER FOUR-

Conclusions, Discussion, and Future Directions
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4.1 Conclusions

Although apoptosis is central to the embryonic development and maintenance of adult
tissue homeostasis in multicellular organisms, the ability for animals lacking central regulators of
apoptosis to survive through embryonic development and grow into adulthood, albeit at low
frequencies, clearly indicates the existence of alternative modalities of cell death. The discovery
of programmed forms of necrotic death, long dismissed as a passive outcome of exposure to
unmanageable physico-chemical stresses, represents a significant conceptual advance for the
field of cell death research. But more than that, the potential implications of this conceptual
revolution for the management of human injury and disease are huge. Cellular necrosis is an
important cause of tissue injury, and hence morbidity and mortality, under many pathological
conditions such as during a heart attack or stroke, and in neurodegenerative diseases.
Furthermore, the eventual ability to manipulate programmed necrosis pathways will likely open
broad new avenues for the treatment of cancers that are refractory to current therapeutics due to
impaired apoptosis. Being a new area of research in a field that has long concentrated its efforts
on apoptosis, the regulatory mechanisms and life versus death determinants of programmed
necrosis are just starting to be revealed, and only for a select few death signals. In this thesis, I
sought to increase our knowledge of how cells make life or death decisions in the context of
programmed necrosis.
In Chapter 2, I demonstrated that the less-oxidized intracellular redox environment
created by ΔNp63α in apoptosis incompetent p53, Bax, and Bak TKO MEFs not only rescued
them from DNA damage-induced necrosis in the short term, but also enhanced long-term
clonogenic survival. I further showed that loss of endogenous ΔNp63α creates a more-oxidized
redox environment in human cancer cell lines, increasing their sensitivity to oxidant- and
chemotherapeutic agent-induced death. Finally, in a situation analogous to deficiency of Bax and
Bak, co-expression of antiapoptotic BCL-2 and ΔNp63α enhanced the long-term survival of
immortalized human mammary epithelium cells that have lost contact with the extracellular
matrix. These findings establish a central role for the intracelluar redox status in determining the
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life-or-death outcome of exposure to intrinsic death signals. They also identified an important new
function for ΔNp63α.
In Chapter 3, I extended our prior study into DNA double strand break-induced
programmed necrotic death by investigating the molecular basis of reactive oxygen species
(ROS) induction in this setting. My findings described a novel mechanism for increased ROS
production, in which double strand breaks upregulate the activity of the electron transport chain
(ETC) complex III. Importantly, RNAi-mediated knockdown of the complex III RISP subunit,
-/-

-/-

essential for its ability to produce superoxide, protects Bax Bak DKO MEFs from double strand
break-induced ROS and necrosis. My data also suggested that induction of complex III activity,
ROS, and cell death is mediated by the ATM/ATR/DNA-PK DNA damage signalling pathway.

4.2 Discussion and Future Directions

A potential role for ΔNp63α in the redox regulation of stem cells
I demonstrated in Chapter 2 that by coordinately upregulating glutathione production and
utilization, ΔNp63α increases cellular resistance to oxidative stress and cooperates with apoptotic
inhibition to promote long-term survival. Recent studies in stem cells highlight the need for long1

lived cells to effectively maintain redox homeostasis . Stem cells in adult mammals can undergo
both self-renewal and differentiation, enabling them to replace mature cells lost to injury, damage,
disease, or normal cellular turnover. Since stem cells must remain capable of both regenerating
themselves and replacing lost progeny throughout an organism’s life, they have been proposed to
1

require increased resistance to the long-term effects of ROS and oxidative stress . Furthermore,
physiological levels of ROS can also function as second messengers that drive proliferation and
2

differentiation . Therefore, elevated ROS levels may compromise stem cell maintenance by
3

inducing excessive cell cycle entry, resulting in premature exhaustion of the stem cell population .
In support of this, hematopoietic stem cells (HSCs) from Atm and FoxO knockout mice have
increased levels of ROS and decreased reconstitution capacity compared to wild-type, defects
that could be rescued with the antioxidant NAC
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. Furthermore, a population of ROS-low HSCs
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has been identified that has increased reconstitution capacity compared to ROS-high
6

counterparts . Stem cells of the normal mammary epithelium and of the central nervous system
also have lower ROS levels than their more mature progeny. ΔNp63α is highly expressed in the
basal layer of the stratified epithelium, where epidermal stem cells required for skin development
7

and homeostasis are located . The profound defects in stratified epithelium development in the
7

p63-null mouse are due to impaired stem cell function . Debate remains over whether this defect
is due to decreased stem cell proliferative capacity or to impaired differentiation

8, 9

. In either case,

my data on ΔNp63α-mediated redox control highlight a potentially critical mechanism used by
epithelial stem cells to maintain proper function.

Importance of redox control for tumorigenesis and cancer cell survival
My findings in Chapter 2 also open new avenues for exploring the role of ΔNp63α in
cancer biology and may lead to new treatment strategies. Similar to stem cells, there is evidence
that cancer cells also have an increased need for antioxidants compared to normal tissue, likely
due to metabolic derangements that increase ROS production

10,11

. The importance of

antioxidants for tumorigenesis is highlighted by a recent report demonstrating that endogenous
oncogenic alleles of Kras, Braf, and c-Myc increase baseline activity of the transcription factor
12

Nrf2, a master regulator of the antioxidant response . The same study also showed that
tumorigenesis in mouse models of pancreatic and lung cancer was impaired by genetic deletion
12

of Nrf2 and that antioxidant genes are increased in human pancreatic cancer . This altered redox
status of cancer cells presents a potential way of achieving therapeutic selectivity in cancer
13

therapy, through inducing ROS generation and/or impairing its elimination . In support of this
strategy, a recently identified small molecule inhibitor of the stress response to ROS killed cancer
cell lines in vitro, caused regression of tumor xenografts in mice, and displayed anti-tumor effects
in a transgenic mouse model of spontaneous breast cancer, all while having minimal effects on
14

non-cancerous cells . Analogous to normal tissue stem cells, redox control may also be
particularly important for cancer stem cells (CSCs), a subpopulation of cancerous cells with stem
11

cell properties proposed to play a major role in relapse and metastasis . Breast tumor CSCs
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were found to have lower ROS levels than cancer cells from a non-tumorigenic population and
15

have increased clonogenic survival following exposure to ionizing irradiation (IR) . Furthermore,
15

pharmacological depletion of glutathione resulted in sensitization to IR . ΔNp63α is
overexpressed in many types of solid tissue tumors and has been reported to function as an
oncogene

16, 17

. Cancers in which it is overexpressed tend to be less-differentiated and more
16

aggressive, with increased resistance to treatment and worse progenosis . Notably, ΔNp63α is
strongly expressed in the putative adult breast stem cell compartment and also in basal-like
breast cancer, a clinically-aggressive, poorly-differentiated subtype with stem cell-like features
16

7,

. These findings combined with my data points to an important role for ΔNp63α -mediated redox

control in the maintenance of CSCs in solid tumors and in their resistance to cancer therapy.
Furthermore, tumors expressing ΔNp63α may be overly-reliant on elevated antioxidants to
counteract high baseline levels of ROS, and thus may be uniquely susceptible to chemotherapy
designed to compromise the antioxidant defences.

ΔNp63α may mitigate matrix detachment-induced defects in fatty acid β-oxidation
In Figure 4 of Chapter 2, I presented evidence that co-expression of ΔNp63α and BCL-2
successful protected loss of short-term viability and enhanced long-term survival of MCF-10A
immortalized human mammary epithelial that have lost attachment to the extracellular matrix. The
role of ΔNp63α in regulating glutathione metabolism plays an important role in mediating this
effect, as reduction of oxidative stress with exogenous antioxidants has been shown to cooperate
18

with BCL-2 overexpression to enhance short-term and long-term survival in this setting . In that
study, matrix detachment-induced ROS was suggested to compromise cell survival by inhibiting
18

energy-production via impairing fatty acid β-oxidation . Though their study did not demonstrate
how ROS inhibits β-oxidation in this setting, this is a reasonable outcome of matrix detachment18

induced oxidative stress . β-oxidation of long-, medium-, and short-chain fatty acids occur in the
mitochondria matrix. The process begins with the activation of fatty acids into acyl CoAs at the
19

mitochondria outer membrane . Long-chain acyl CoAs are transported into the mitochondrial
matrix via the carnitine cycle, which involves conversion to acylcarnitines by CPT1 at the outer
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membrane, transport through the inner membrane via the bidirectional carnitine:acylcarnitine
translocase CACT, and conversion back into acyl CoA by CPT2 at the matrix-face of the inner
19

membrane . Once in the matrix, long-chain acyl CoA species are oxidized by inner membranebound enzymes while medium- and short-chain species are oxidized by soluble matrix
19

enzymes . The location of these enzymes in the mitochondrial matrix makes them vulnerable to
mitochondrial ROS; the inner membrane-bound enzymes and CACT are patricularly vulnerable
due to their proximity to the ETC located in the inner membrane and to potential disruption due to
lipid peroxidation-mediated membrane damage. In Chapter 2, I reported that ΔNp63α inhibits
DNA double strand break-induced ROS, and provided evidence in that chapter and in Chapter 3
that the source of ROS is the mitochondria. Given these findings, it will be interesting to
determine whether ΔNp63α is enhancing long-term survival of matrix-detached MCF-10A through
alleviation of oxidative stress-induced defects in β-oxidation in the mitochondrial matrix.

Mechanism for induction of ETC complex III activity by DNA double strand breaks
In Chapter 3, I provided evidence that DNA double strand breaks induce ROS production
through increasing the intrinsic enzymatic activity of ETC complex III. This may occur through
either transcriptional or post-transcriptional mechanisms. However, assembly of functional
complex III homodimers in the mitochondrial inner membranes is a complex, multi-stage
20

process , and is less likely to account for acute changes in total ETC complex III activity
compared with post-translational regulatory mechanisms. Since we had previously reported that
21

double strand break-induced ROS requires de novo gene expression , the most likely
mechanism for ROS induction is the transcriptional upregulation of a regulatory protein that alters
the activity of existing complex III subunits via protein modification. Two potential transcriptional
regulators downstream of ATM/ATR/DNA-PK in this scenario are the transcription factor p73 and
the transcriptional co-activator PGC-1α, as discussed in Chapter Three. Though complex I has
22

23

24

been described to be regulated via phosphorylation , nitrosylation , and acetylation ,
mechanisms for post-translational regulation of complex III have not been adequately
characterized. A proteomic study has identified several sites on complex III that undergo
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phosphorylation including the Rieske iron-sulfur protein (RISP) subunit reponsible for complex III
superoxide production
-/-

25

. We showed in Chapter 3 that RNAi-mediated knockdown of this subunit

-/-

protected Bax Bak DKO MEFs against DNA double strand break-induced ROS and necrosis. It
will be very interesting to determine whether this subunit does indeed undergo changes in
phosphorylation status in the setting of DNA damage-induced programmed necrosis. If so, then
the follow-up experiments will focus on characterizing the functional significance of this,
identification of the responsible kinase(s) and/or phosphatase(s), and on determining how these
are regulated by the DNA damage response pathway, either through p73, PGC-1α, or other
transcriptional regulators.

4.3 Concluding Remarks
Although apoptosis is a complex, highly-regulated process, heroic efforts in the field have
revealed many of its mysteries. Yet, it is instructive to recall that the term “apoptosis” did not even
exist until four decades ago. That’s less than two generations of investigators. Indeed, many of
those whose early work were fundamental in elucidating the pathophysiological roles and
regulation of apoptosis are still active and, indeed, at the forefront of cell death research. Yet,
their focus, and the focus of the field, is now turning towards a new paradigm in cell death with
profound implications for human health and disease: programmed necrosis. Necrosis is a form of
cell death central to the morbidity and mortality caused by heart attacks and stroke, two of the
leading causes of death in the developed world, and also by other injuries and diseases such as
acute pancreatitis and neurodegenerative disorders. It has long been dismissed as a passive
and, worse, inevitable consequence of exposure to unmanageable physico-chemical stresses
such as prolonged ischemia. Thus, the demonstration of molecular controls for necrosis, not just
in vitro but in diverse animal disease models, represents not simply a conceptual revolution but
also the opening of broad new avenues for therapeutic intervention. I am confident that the
brilliant, dedicated scientists and their scientific progeny who have done so much to unravel the
secrets of apoptosis over the past few decades will do the same for necrosis in the decades to
come, for the benefit of all mankind.
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